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ABSTRACT OF DISSERTATION 
 
 
 
CROSSTALK BETWEEN GASTROINTESTINAL EPITHELIAL CELLS AND RESIDENT 
MICROBIOTA PROMOTES IMMUNE HOMEOSTASIS  
  
The gastrointestinal tract houses one of the most dense and diverse communities of bacteria on 
the planet.  The mutualistic relationship between the host and commensal microbe permits the 
microbe an ideal environment to grow and provides the host with increased caloric intake, 
maturation of the adaptive immune system, and resistance against invading pathogens.  To 
maintain a system in which both parties benefit, the epithelium has evolved numerous strategies 
to ensure epithelial cells respond to microbes appropriately and that potentially hazardous 
commensals remain distanced from the soma proper.  Breakdown of these propitiating 
mechanisms elicits unchecked inflammation and can lead to pathology and reduction of host 
fitness.  We show that oral and intestinal epithelial cells respond to the circulating hormone 
adiponectin in the presence of bacterial constituents, and that adiponectin has the potential to 
downregulate NF-κB signaling.  We also show many commensal bacteria have no effect on TNF 
or IL-8 proinflammatory gene expression in intestinal cells.  Commensals within the family 
Enterobacteriaceae can increase TNF and IL-8 expression, but also expression of the NF-κB 
regulator A20 and MAPK phosphatase MKP-1.  Importantly, Enterobacteriaceae also increased 
expression of the IgA transporter pIgR.  In the mouse model, we show pIgR expression along the 
intestinal epithelium is necessary for SIgA accumulation in the outer mucus layer where 
commensal bacteria reside.  Loss of the mucus layer, but not pIgR is sufficient to allow direct 
bacterial-epithelial cell contact and induce spontaneous inflammation along the colon.  Secretory 
IgA is supplied maternally through breast milk early in life to compensate for the neonate’s 
inability to produce sufficient endogenous amounts.  By utilizing a breeding scheme in which 
mouse dams were unable to provide their offspring with SIgA, we show the necessity of 
maternally-supplied SIgA to control bacterial invasion to mesenteric lymph nodes before 
weaning.  In addition, 8-10 week old adult offspring not receiving SIgA as neonates showed both 
a unique intestinal microbiota and different patterns of intestinal epithelial cell gene expression 
with and without chemically-induced acute colitis.  In summary, we reveal new mechanisms the 
mammalian host utilizes in order to maintain peace between the commensal microbe and host 
immune system.     
         Eric W. Rogier  
         July 30, 2012 
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Chapter 1 
INTRODUCTION 
 
mu’tu·al (mū’choo-əl) adj. 1, preferred, exerted, or performed by each other with respect to each 
other; reciprocal. 2, denoting a company whose members share the expenses and the profits 
                        -The New American Webster Dictionary  
 
 Friendships are sometimes difficult to maintain.  Occasionally, one party will attempt to 
benefit at the expense of the other, and the resulting conflict may require long amounts of time to 
resolve and repair the relationship.  Humans deal with these interpersonal issues on a daily basis, 
but rarely give thought to the interchange between two entities that has been happening within 
their own bodies since the minute they were born.  During birth, infants must endure the 
monumental transition from an environment in which they are the sole organism to an 
environment where other organisms not only exist, but share intimate cohabitation.  Most of these 
organisms we cannot see, and these microorganisms colonize infants at the moment of birth with 
the vast majority of the microbes belonging to the domain Bacteria (1).  This colonization has 
deep evolutionary roots within the kingdom Anamalia, and is seen among many branches of the 
evolutionary tree, including: insects (2), fish (3), and higher vertebrates (4, 5).  In humans, the 
highest degree of bacterial colonization in or on the body is found along the length of the 
gastrointestinal (GI) tract (6).  At its essence, the GI tract is simply an elongated tube beginning at 
the mouth and extending to the anus, but this tube isn’t simply an inert barrier.  Throughout 
evolutionary history, humans and other mammals have evolved complex systems at each of the 
unique sites along the GI tract to allow for not only tolerance of the bacteria which reside at the 
GI surface, but also the formation of a mutualistic relationship with the resident bacterial 
population – also frequently referred to as the microbiota (7, 8).  The surface of the GI tract which 
is exposed to the outside environment is composed of the subunit of the epithelial cell, which, 
collectively, is denoted as the GI epithelium.  At this interface, bacteria and their human host are 
in constant communication with each other by various molecular signals. Since disruption of this 
inter-Domain dialogue can be grave for both the bacterium and the host, the epithelium employs 
multiple redundant systems that are in place to ensure the peace is kept.  The oral cavity and 
intestine are the two sites along the GI tract which are in contact with the highest concentrations 
of bacteria (9, 10), so our focus will be the mechanisms used by these two sites to maintain a 
cordial relationship with the resident microbiota.              
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A. VARIABLE STRUCTURE OF THE GI EPITHELIUM AND RESIDENT BACTERIA 
 
The oral epithelium: Friends by association 
 The epithelium within the oral cavity (oral mucosa) is characterized as stratified 
squamous epithelium, and is further sub-classified depending on the presence or absence of 
keratin (11, 12).   Non-keratinized epithelia of the mouth are classified at lining mucosa and 
constitute the cheek and other soft epithelium.  The hard palate on the mouth’s roof and gingiva 
surrounding the teeth are both examples of masticatory mucosa.  Figure 1.1a illustrates the                    
amorphous, stratified nature of the oral epithelium and the cell types located directly beneath.  
Fibroblasts underneath the epithelium quickly replace constantly shedding epithelial cells, while 
macrophages (among other local myeloid and lymphoid cells) allow for localized immune 
responses (12).  Figure 1.1b shows a section of human oral tissue which has been stained with 
hematoxylin and eosin (H&E stain) to emphasize different cell types present in the tissue.  The 
stratified nature of the epithelium and delineation between epithelial cells and other underlying 
cell types is also clearly apparent. 
As profiling of bacterial communities has moved away from culture-dependent  and 
microscopic methods to high-throughput genetic sequencing, the definifition of a unique bacterial 
‘species’ has been blurred due to obvious genetic differences between bacteria, but no discernable 
morphological, metabolic, or other biological variance. More recently, the idiom ‘phylotype’ or 
‘operational taxanomic unit’ (OTU), which relies on sequence similarity of 16S rRNA, is 
commonly used to segregate bacteria (8).  A common standard for stating two bacteria are both of 
the same species/OTU is a rRNA sequence similarity of >98% (13), and will be used in this 
document to designate unique bacteria.        
            The human mouth is home to approximately 100-500 distinct bacterial species (11) which 
frequently colonize the gingiva at the border of tooth and tissue.  The current paradigm for 
bacterial organization within the oral cavity is shown as a multi-species biofilm where bacteria 
and occasional single-celled eukaryotes share a common biological scaffold (10, 14).  This 
framework is known as the exopolysaccharide matrix (EPS matrix, or ECM ) and is composed 
from an amalgam of secreted bacterial sugar derivatives (15).  In a clinical setting, prolonged 
ECM accumulation leads to dental plaque, which hardens to calculus if not removed regularly.  
Currently, the spatiotemporal model of bacterial colonization helps to explain community 
dynamics by dividing the oral microbiota into early and late colonizers (10).  Early colonizers 
include multiple species within the genera Streptococcus and Actinomyces which are able to 
associate with host salivary pellicle proteins including: mucins, agglutinins, and amylases (16, 
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17).  These early colonizers stimulate biofilm formation by coaggregation with later successive 
colonizers and secretion of EPS substrate.  Late colonizers include Fusobacterium nucleatum, 
Treponema denticola, and many others which allow further enhancement of the multi-species 
biofilm by continued coaggregation with neighboring bacteria and secretion of quorum sensing 
molecules (10).  While the aforementioned bacteria are regular inhabitants of the oral mucosa, 
determining consistent relative percentages of constituents of the oral microbiota by phylum or 
any lower taxanomic order is difficult due to the dynamic nature of the location.  However, 
current efforts are underway through the Human Microbiome Project to try to identify a ‘core 
microbiome’ in the mouth which is unanimous for all humans.  The bacterial species which do 
inhabit the mouth are rarely found outside this environment, showing the specifically-evolved 
dynamic of the residents for this particular site (10). 
 
The small intestinal epithelium: Mountains beyond mountains 
 The organ in the human body with the greatest surface area exposed to the outside 
environment is the small intestine, which has a surface area approximately the size of a squash 
court (18).  All three sections of the small intestine: duodenum, jejunum, and ileum, are all lined 
by a specialized simple epithelium, which allows digestion of water and nutrient absorption (19).  
The morphology of this specialized epithelium is arranged into units of crypts, which invaginate 
into the epithelium, and villi, which extend like pillars above the epithelium.  These structures 
greatly increase the surface area of the organ and allow for greater nutrient uptake, but also 
allowmore exposure to the outside environment and all possible threats associated with it.   
As with the oral cavity, the cells constituting the small intestine epithelium are constantly 
being renewed, and it is estimated the entire epithelial surface is replaced within a span of 4-5 
days (19).  After much early debate, this process has been better illuminated by the discovery of 
the existence bona fide intestinal stem cells which display characteristics of stem cells in other 
compartments in the body (20).  However, controversy still remains about the exact 
characteristics of this cell type since multiple cells with both unique gene expression patterns and 
displaying different cell surface markers have been shown to have stem cell-like properties of 
self-regeneration and differentiation into less-potent cell types (21).  After the initial introduction 
of intestinal stem cells (ISCs), two hypotheses preside with one based on the quiescent feature of 
adult stem cells (called the +4 Label-Retaining Cell, LRC) and the other based on functional and 
genetic evidence (Lrg5+ Crypt Base Columnar, CBC, cell) (22, 23).  Both of these cells reside 
near the bottom of the intestinal crypt with +4 LRCs at four cell widths from the lowest point of 
the crypt and Lrg5+ CBCs interspersed along the crypt base.  More recently, this paradigm has 
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been modified with the finding that +4 LRCs express the hematopoietic and neural stem cell gene 
Bmi1, and the concept that two distinct types of ISC populations exist (24), which may even be 
able to replenish each other’s populations in times of stress or injury (25).  The stem cells in the 
intestine differentiate into two classes: absorptive and secretory.  Cells in the absorptive lineage 
(absorptive enterocytes) are dependent upon expression of the transcription factor Hes1 which 
arises from Notch signaling in the ISC early in differentiation (19, 22).  Conversely, intestinal 
secretory cells (goblet, enteroendocrine, and Paneth cells) all express the Math1 transcription 
factor, which is a result of ISC signaling through the Wnt pathway.  Both of these transcription 
factors antagonize the expression of the other in the same cell, so cells maintain a committed 
lineage once beginning differentiation.   
Absorptive enterocytes constitute the majority of epithelial cells (~75%) on the small 
intestinal epithelium and serve to take in dietary nutrients, absorb water, and regulate ion 
exchange.  Along the apical surface of this cell type are structures known as microvilli (which, 
collectively, is termed the brush border) which allow for further augmentation of available 
surface area to complete these biological processes (21).  Located deep within the crypts and 
interspersed within ISCs, Paneth cells function as innate immune cells by secreting antimicrobial 
peptides and lysozyme (19, 26).  Enteroendocrine cells make up a very small percentage of the 
epithelium (~5%) and secrete hormones into the intestinal lumen.  The most prevalent cell type 
from the secretory lineage is the goblet cell (10-15%), which is responsible for excretion of 
mucus into the intestinal lumen.  Figure 1.1c shows the organization of the crypt-villus axis with 
the perpetual requirement for intestinal epithelial cell (27) renewal due to constant cells shedding 
from the villus apex.  Shown to the right is the basic schematic for ISC migration and 
differentiation into the for epithelial cell types.  The left side of Figure 1.1d shows an H&E 
stained section of a mouse small intestine with both the villus and crypt displayed.  To the right 
are the four epithelial cell types shown in situ: b) goblet cells stained positive for mucus with 
periodic acid-Schiff,c) an enteroendocrine cell stained positive for synaptophysin, d) paneth cells 
stained positive for lysozyme, e) and absorptive enterocytes stained positive with alkaline 
phosphatase.       
Another cell type found along the distal section of the small intestine is the microfold cell 
(M cell).  Constituting less than 3% of epithelial cells in the distal jejunum and length of ileum in 
humans, these cells play a unique role in the sampling of bacteria and other particles from the 
intestinal lumen and assisting in the development of the host-driven adaptive immune response 
(17, 28).  These cells are present mainly in conjuncture with the follicle-associated epithelium 
(FAE), which manifests as isolated lymphoid follicles (ILFs) and Peyer’s patches (PPs) in the 
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distal small intestine (29-31).  M cells line the surface of these structures to allow for antigen 
sampling of luminal contents and the subsequent genesis of appropriate immune responses by 
dendritic cells (DCs), T cells, and B cells directly underneath the epithelial surface.  Afferent 
lymphatic drainage from the small and large intestine to neighboring mesenteric lymph nodes 
(MLNs) also provides a site for adaptive immune cell maturation by way of bacterial and other 
antigens present in the intestinal lumen (31).       
 An immense pH gradient exists from the duodenum to the distal ileum which has large 
implications for the bacteria trying to colonize the different sites.  Bacteria able to withstand the 
high concentrations of hydrogen ions from the duodenum through the jejunum predominantly 
include species within the genera Streptococcus and Lactobacillus (9, 17).  However, even these 
microbes do not necessarily thrive under these conditions, as bacterial concentrations only creep 
into amounts of 102 bacterial/mL luminal contents.  The ileum provides a more alkaline 
environment – exposing niche availability and allowing greater bacterial diversity and quantity 
(32).  In the ileum, bacteria within the phylum Firmucutes and Bacteroidetes begin to establish 
successful colonization, and concentrations reach upwards of 108 bacteria/mL luminal contents 
(9).  For these reasons, it is no coincidence that FAE structures begin to appear at the terminal 
jejunum, and increase in prevalence as one moves toward the distal ileum.  Bacterial communities 
in the small intestine are loosely arranged due to the absence of an organized mucus layer, and 
often are found in adherence with transient food particles or detached mucus globules (33).       
 
The large intestinal epithelium: Divide and colonize                             
 With respect to morphology, the most profound difference between the small and large 
intestine is the absence of villi in the latter.  Crypts extend deep into the lamina propria 
underneath the surface, but retain their small diameter, giving the large intestinal epithelium a 
smooth appearance.  The cell types of this epithelium remain the same as in the small intestine, 
but in dissimilar quantities.  Absorptive enterocytes still constitute the majority of epithelial cells, 
but the enteroendocrine and Paneth cells of the secretory lineage are almost non-existent (19).  
With the exception of low numbers in the caecum, Peyer’s patches are mostly absent from the 
large intestine, so M cells are only found when in association with ILFs (31).  Even with the 
deficit of other secretory cells, goblet cells still show a strong presence in the large intestine, 
constituting around 20% of all cells on the epithelium.  The combination of a relatively smooth 
surface and increased presence of mucus-secreting goblet cells allows for the development of a 
structured mucus layer which increases in thickness from the cecum to the end of the GI tract at 
the rectum (34).  This mucus layer has two distinct divisions: a tightly-packed inner mucus layer 
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and less-dense outer mucus layer (35, 36).  Proteins within the Mucin family provide the 
scaffolding necessary to form these layers (37). 
Immediately following the distal ileum, bacterial density and community diversity 
explodes as aided by more neutral pH and structure of large intestine (9).  Concentrations of 
bacteria start around 109 microbes/mL in the cecal contents and rise to within 1012 bacteria as one 
nears the rectum.  Throughout the length of the large intestine in humans, members of the 
bacterial phylum Firmicutes preside as the dominant inhabitants, composing 50-60% of all 
unique bacteria (38).  Within this phylum, it is estimated upwards of 95% of these bacteria belong 
to the class Clostridia.  The phylum Bacteroidetes includes the next highest abundance of large 
intestinal bacteria with 30-40% of bacteria included under this taxonomy.  Within Bacteroidetes, 
species within genus Bacteroides have been the closest studied intestinal bacteria, and have been 
found to contain a plethora of adaptations that adjusted for life within the intestine (39, 40).  The 
phyla Proteobacteria and Actinobacteria each compose around 5% of the large intestinal 
microbiome, while other phyla of lesser abundance commonly present in humans include 
Verrucomicrobia, Fusobacterium, and the candidate phylum TM7 (38, 41).  It is thought that 
biofilms also play an important role in community dynamics for bacteria residing within the 
intestine (42, 43), but this has not been assessed as thoroughly as in the oral cavity.      
Figure 1e illustrates the basic structure of the large intestinal epithelium with mucin 
secretion from goblet cells providing overlying mucus layers and the majority of bacterial 
habitation in the outer mucus layer.  Immunoglobulin A (IgA), as well as antimicrobial proteins 
are also found within the mucus layers, and will be discussed in depth in Section C.  Figure 1.1f 
shows an H&E-stained section of a mouse colon showing deep penetration of crypts into the 
lamina propria and formation of the luminal mucus layer by goblet cells exudates.      
 
B. COMMUNICATION BETWEEN HOST AND MICROBE 
 
Pattern recognition receptors and intracellular signaling pathways 
 The innate immune system provides multiple opportunities for any bacterium or bacterial 
product to be recognized by the host through a diverse array of pattern recognition receptors 
(PRRs) on the plasma membrane surface, within the endosome, and throughout the cytoplasm of 
epithelial cells (see Fig. 1.1g).  The biological ligands for these receptors are known as microbial-
associated molecular patterns (MAMPs).  For the purposes of focusing on epithelial cells , the C-
type lectin PRRs, which are primarily expressed on the surface of myeloid-derived cells, will not 
be discussed (44).  Likewise, the viral PRRs including Rig-like helicases (RLHs) and Toll-like 
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receptors (TLRs) 3,7,8,9 will also not be discussed (45).  Currently, the plasma membrane-bound 
TLRs are separated by numerical classification according to which microbial pattern they 
recognize.  All TLRs share a common structure as a Type 1 transmembrane glycoprotein with an 
ectodomain containing a series of leucine-rich repeats which allow for recognition of microbial 
molecular patterns (17)   The heterodimer of TLR1 and 2 recognizes triacylated lipopeptides from 
Gram (-) bacteria, and heterodimer TLR2/6 recognizes diacylated lipopeptides from Gram (+) 
bacteria and mycoplasma (46).  The flagellin subunit of bacterial flagella is recognized through 
TLR5 while TLR4 is activated by certain kinds of bacterial lipopolysaccharide (LPS).  
Importantly, certain bacteria within the intestinal microbiota have been shown to inhibit TLR4 
responses through production of LPS derivatives with different acylation and phosphorylation 
patterns on the Lipid A motif (47, 48).  Mutualistic bacteria within the phylum Bacteroidetes 
have a ‘monotonously similar’ Lipid A composition with two phosphate and four primary acyl 
chains which is virtually unrecognized by the Cd14-MD2-TLR4 signaling complex (47).  Lipid A 
molecules with 6 acyl chains and multiple phosphate groups provide the most potent stimulus for 
TLR4 activation, and are found on many human pathogens within the phylum Proteobacteria 
(48). 
 Even if bacteria or their products are able to bypass plasma membrane TLRs, the family 
of cytoplasmic Nucleotide Oligomerization Domain-like receptors (NOD-like receptors, NLRs) 
allows for further detection by the host cell (49).  The NOD receptors NOD1 and 2 both 
recognize peptidoglycan from Gram (+) bacteria, but only NOD 2 is able to identify 
peptidoglycans from Gram (-) microbes (50, 51).  More NLRs such as IPAF, CIITA, NAIP, and 
the pyrin domain-containing NALPs can also initiate signaling pathways in the presence of 
MAMPs (49).  Just by observation of sheer variety and quantity, it is clearly apparent that it is to 
the benefit of the host to be able to sense and respond to bacteria on the epithelial surface. 
All plasma-membrane bound TLRs utilize the adaptor protein myeloid differentiation 
primary response gene 88 (MyD88) to initiate downstream signaling cascades in response to 
microbial products (46).  In turn, MyD88-mediated signaling is able to activate both the mitogen-
activated protein kinase (MAPK) and nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB) pathways.  Cytoplasmic NOD1 and 2 are also able to perpetuate NF-κΒ signaling, 
although through a different adaptor protein, RIP-like interacting CLARP kinase (also, 
RICK)(52).  Signaling through the canonical NF-κΒ cascade requires translocation of the 
p50/p65 NF-κΒ heterodimer to the nucleus of the epithelial cell, where it acts as a transcription 
factor to induce transcription of both pro- and anti-inflammatory genes (53).  Proteins involved in 
the promotion of a mucosal inflammatory response include chemokines such as interleukin 8 (IL-
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8), cytokines assisting in leukocyte extravasation such as tumor necrosis factor (TNF) and IL-1,  
and lymphocyte and leukocyte activators such as IL-12, IL-13, and interferon gamma (IFNγ)(54).  
Other proteins are secreted by the epithelium in order to diminish inflammatory signaling, and 
include the apoptosis-inducing transforming growth factor beta (TGFβ) and NF-κB-inhibiting IL-
10.  In addition, epithelial cells produce proteins which remain intracellular and inhibit NF-κB 
signaling. Peroxisome proliferator-activated receptor gamma (PPARγ) shuttles the NF-κB 
heterodimer out of the nucleus, while A20 prevents NF-κB translocation from taking place (55, 
56).  Since nuclear translocation is one of the terminal events in the NF-κΒ cascade, determining 
amount of NF-κΒ in a cell’s nucleus is a common way to measure the impact microbial products 
have had on cell stimulation through PRR signaling (57, 58).  The intestinal mutualist 
Bacteroides thetaiotaomicron has been shown to directly attenuate pathogen-induced 
inflammatory responses through inhibition of NF-κΒ signaling in vivo and in vitro by PPARγ 
(59).  Figure 1.1g identifies many of the PRRs and their respective ligands as well as the 
intracellular signaling pathways used by cells along the epithelium to sense pathogens and the 
resident microbiota.      
 
Short chain fatty acids and their receptors 
 Pattern recognition receptors are directly involved in the detection of MAMPs that are 
shed from living or dead bacteria, but other metabolic products are recognized by the epithelium 
that convey multiple benefits to the host.  Many ingested complex polysaccharides not utilized by 
the host due to lack of appropriate digestive enzymes are readily used as the primary food source 
for bacteria along the GI tract, with the highest areas of utilization at the cecum and proximal 
colon (60).  From the metabolism of these complex molecules, bacteria produce numerous short 
chain fatty acids (SCFAs) with the three of highest intestinal concentration being acetate, 
propionate, and butyrate.  These SCFAs are easy energy sources and readily absorbed by the 
intestinal epithelium and can be found in systemic circulation.  Current estimates state that a 
healthy individual gains upwards of 15% of their daily caloric intake from bacterial metabolic 
products, and this hypothesis is well-supported by the fact that mice lacking an intestinal 
microbiota are much leaner than their microbe-exposed counterparts (61, 62).  On a more 
immunological basis, SCFAs are widely thought to potentiate anti-inflammatory responses 
through activation of host G-protein coupled receptors Gpr41 and 43 (60, 63).  Signaling through 
the type II interferon receptor and canonical NF-κΒ pathway have both been shown to be 
attenuated after treatment with SCFAs (64, 65).  Furthermore, experimental models of 
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inflammation in animals deficient for SCFA receptors have shown worse disease in sites far 
removed from the GI tract (61, 63), implicating microbial-derived SCFAs in the aid of global 
inflammation control. 
                  
C. HOST AND BACTERIAL MECHANISMS FOR MAINTAINING HARMONY 
 
Early establishment of an advantageous microbiota 
  Upon entry into the world, the newborn infant has unknowingly just created a new niche 
for microbes to thrive on and within its body (6).  These bacteria will populate this human’s skin 
and mucosal surfaces perpetually over tens of thousands of binary fission events, and will remain 
until the human body expires.  As with many things in a newborn’s life, the first exposure to 
bacteria is out of the child’s control, and recent evidence suggests early microbial composition in 
the infant is mostly dependent upon mode of delivery.  Children born via vaginal delivery tend to 
possess a more diverse microbiota in both the oral cavity (66) and along the intestinal tract (67, 
68).  Very strong correlations exist between the vaginal microbiota of the mother and intestinal 
microbiota of the naturally-born infant (69).  Conversely, the microbiota of a cesarean infant is a 
mirror-image of the mother’s skin bacterial community.    
In humans, the first year of life is known to be a particularly dynamic period of shifts in 
bacterial density and composition (1, 70), but these perturbations tend to wane as the child moves 
beyond the first few years (71).  In addition to providing the initial inoculum to germinate the 
neonate’s microbiota, the mother is also able to continually cultivate this developing biome 
through products in the breastmilk.  Some oligosaccharides in human milk are resistant to human 
digestive enzymes (72), and their only perceived purpose is to provide a food source for 
expanding microbial communities – specifically bacteria within the genera Bifidobacterium and 
Bacteroides whose genomes are well-adapted for scavenging these molecules. (73, 74).  Infants 
on formula-only diets, which would lack many of these human oligosaccharides, tend to have 
higher amounts of Firmicutes and Proteobacteria along their intestinal mucosa when compared to 
their breast fed peers (70).   
Another abundant milk product that has not received as much attention are the mucosal 
antibodies that are directly transferred to the GI tract of the nursing infant (Chapter 5).  As 
opposed to immunoglobulins the infant would be able to produce (termed active antibodies), the 
maternal supplementation of immunoglobulins to the infant is referred to as transfer of passive 
antibodies.  Immunoglobulin A (IgA), IgG, and IgM are all present in human breast milk, but IgA 
far exceeds the other immunoglobulins in quantity by constituting an impressive 4% by weight of 
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colostrum and 0.1% of mature milk (17).  As IgA and IgM both require the polymeric 
immunoglobulin receptor (pIgR) to traverse epithelial barriers (75), the release of these antibodies 
from pIgR in the mammary epithelium creates a new molecule of secretory IgA (SIgA) or SIgM.  
Multiple studies have shown SIgA in the promotion of biofilm formation on the oral epithelium 
(76) and in the gut (77, 78), but never by SIgA received through maternal transmission.  It is 
tempting to speculate that maternal milk may promote a benevolent microbiota by a two-pronged 
approach: a) providing prebiotics to stimulate growth of mutualistic bacteria, and b) 
supplementation with SIgA to frame the mutualists into an enduring biofilm.  Proper community 
establishment by IgA extends far beyond the Bacteria domain, as SIgA is able to inhibit invasion 
of enteric viruses such as rotavirus and norovirus (79, 80), which the infant is particularly 
susceptible to.                                    
            
Mucin proteins and the mucus layer  
 Mucins are secreted onto the epithelium throughout the GI tract.  The function of these 
proteins is site-specific, and the relative mucin protein concentrations vary widely between sites.  
Mucin proteins can broadly be classified into two types which are similar in biological function: 
secreted and membrane-bound.  The secreted mucins (muc2,5AB,5B,6) are all located within the 
11p15 locus and serve to form mucus layers on top of epithelial surfaces (37).  The membrane 
bound mucins (muc1,3A,3B,4,12,13), which are still tethered to the epithelial cell, are known to 
serve as steric hindrances to pathogen receptors on the epithelium (33).  The common bond 
between all mucin proteins is the presence of repeating contiguous proline-threonine-serine 
residues (PTS-regions) in which proline flattens the molecule into β-sheets and serine and 
threonine allow for heavy O-glycosylation (37).  Only secreted mucins contain cysteine-rich 
domains, which permit crosslinking of mucin proteins and structure a mucus layer with 
considerable depth.         
 Limited amounts of mucins are secreted into the oral cavity by salivary glands and 
produced by oral epithelial cells.  Mucin5B appears to be the only secreted mucin of appreciable 
quantities, while both muc1 and 4 can be found on the surface of the epithelium (81).   Low 
molecular weight muc5B has been shown to have direct inhibitory affects against agglutination of 
oral pathogens Streptococcus mutans and S. sanguis (82).  In addition, the oral mutualists S. 
oralis and S. gordonii were able to use Muc5B as a nutrient source, but only within the structure 
of a biofilm, and not in the planktonic state (83).   
 Small and large intestinal goblet cells secrete copious amounts of gel-forming muc2, 
which is heavily glycosylated and present in high-molecular weight oligomers as it leaves the 
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cells (84).  Though considerable amount of protein and polysaccharide are present in these mucus 
granules, as a true gel, the main component of the mucus is water.  The buffer zone the mucus 
provides intestinal epithelial cells aids in separating host from bacteria, but mucus layers are not 
simply sedentary barriers.  Bacterial products capable of stimulating TLRs and SCFA receptors 
have been shown to increase mucus production in goblet cells (85-87), implicating a primary host 
response to bacterial recognition is to reinforce the mucus layer.  Further discovery has found that 
germ-free mice possess an intestinal mucus layer of 3-fold decreased thickness when compared to 
conventionally-raised mice (36).  The necessity to form a mucus layer in the intestine is shown by 
the presence of spontaneous colitis in mice deficient for the muc2 protein (88, 89).  After 
extrusion from goblet cells, mucus in the lumen organizes into two distinct layers.  The 
organization and proteins within the two layers are also distinct (Chapter 4).  The outer loose 
mucus layer is less dense and thicker than the inner layer, and is thought to arise from proteolytic 
cleavage of mucin proteins that were initially part of the inner layer (90).  One of the striking 
findings of the outer mucus layer was the presence of bacteria in only this layer in immune-
competent animals (36, 91).  This outer layer actually provides a very suitable niche for many 
mutualists within the intestinal microbiota, and multiple bacteria express proteins that allow 
consumption and metabolism of carbon-rich mucus (92, 93).  Specifically, bacteria within the 
genus Lactobacillus express extracellular proteins with mucus-binding domains (94), while 
inhabitants of the Bacteroides genus produce the Sus family of  proteins which allow mucus 
binding, transport across the periplasm, and enzymatic degradation within the microbe (39, 40).  
Along with offering a dense barrier between the intestinal lumen and host epithelium, the inner 
mucus layer provides a sink for antimicrobial peptides to be deposited after secretion from host 
cells, and will further be discussed in Section 1.9.         
             
The polymeric immunoglobulin receptor and secretory immunoglobulins  
 Though both IgM and IgG can be found in external secretions, IgA secretion along the GI 
mucosa far exceeds amounts of the other two immunoglobulins (17).  Most B cell maturation into 
IgA-producing plasma cells takes place within the PPs and ILFs of the gut-associated lymphoid 
tissue (GALT) (95).  Other appreciable B cell maturation occurs in other mucosal lymphoid 
regions, such as along the nasal (NALT) and bronchial (BALT) epithelia, but the tremendous 
amount of bacterial antigen within the intestinal tract allows the GALT to be a robust site of 
immune cell development.  The importance of a microbiota in development of IgA plasma cells 
(IgA+ PCs) is shown by the germ-free mouse model in which mice never exposed to bacteria and 
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have extensive defects in GALT and MLN development as well as severely reduced IgA+ PC 
numbers and systemic IgA levels (96). 
B cells and plasma cells both produce the ‘J chain’ polypeptide which is able to increase 
immune activity of polymerized IgA and IgM.  Though not required for antibody 
multimerization, the J chain is thought to provide an additional adhesive to the connecting heavy 
chains through disulfide bridging (97).  For the purposes of antibody secretion into the GI lumen, 
the J chain is crucial since it allows binding of polymerized IgA and IgM to the polymeric 
immunoglobulin receptor (pIgR) on the basal surface of epithelial cells. Due to the large size of 
antibody multimers, antibody movement across the GI epithelium requires active transport (98).  
Once bound to pIgR, the antibody-J chain-pIgR complex traverses the epithelial cell through a 
series of endosomal sorting pathways until the apical surface of the epithelial cell is reached (99).  
Once at the apical surface, the pIgR molecule is proteolytically cleaved to release the complex 
into the luminal space which is now referred to as a secretory (S) antibody (e.g.SIgA).  Apical 
cleavage of pIgR can also be achieved when the receptor is not bound, releasing the secretory 
component (SC) fragment into the lumen (100) (Figure 1.1h).                    
 In the oral cavity, SIgA is found in salivary secretions with higher amounts found in 
whole versus parotid saliva (95).  Localized IgA+ PCs are thought to arise from the distant GALT, 
the neighboring NALT, and surrounding salivary glands.  Plasma cells matured outside the oral 
mucosa are able to secrete a more polyclonal antibody which has possible functions in 
agglutination of the resident microbiota and promotion of biofilm development (101).  However, 
infection with the oral pathogens Streptococcus mutans or Actinobacillus actinomycetemcomitans 
both elicit a pathogen-specific antibody response (102, 103) , which is similar to what is observed 
in the GALT after infection with enteric pathogens (104). 
 On a daily basis, the intestinal epithelium devotes an enormous amount of metabolic 
energy to the production of IgA and J chain by plasma cells, creation of pIgR within epithelial 
cells, and endosomal trafficking of immune molecules across the epithelium.  In humans, it is 
estimated the intestinal tract discharges around 3g SIgA daily (105), on top of an additional 82mg 
of free SC (106).  These molecules share redundant functions for the benefit of the host, as well 
as unique protein-specific functions.  The majority of bacteria in the intestine are bound by SIgA 
(107) which provides a protective mechanism to the host through immune exclusion.  Both 
bacteria and their antigens bound by SIgA have a greatly reduced capacity for epithelial invasion 
and stimulation on PRRs on the intestinal surface (100).  Polysaccharide residues on SIgA and 
free SC likely promote association between these proteins and the heavily glycosylated mucus 
layer, allowing for entrapment of bacterial products away from the epithelium (108).  Moreover, 
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the mucin-binding domains of Lactobacillus bacteria have also been found to directly bind SIgA 
(109), suggesting a close association between bacteria, mucins, and SIgA.  As in the oral cavity, 
SIgA in the intestine probably plays a role in the formation of biofilms (77, 78, 110).  Even if the 
epithelial cell is breached by viruses or MAMPs, pIgR-bound IgA in endosomal compartments is 
able to adhere to viruses to thwart replication as well as prevent bacterial antigen activation of 
inflammatory signaling pathways (100, 105).  Increased mucosal leakiness is a hallmark of a 
compromised epithelium, and this allows for antigens to cross the epithelial layer that would 
normally be segregated within the lumen.  The professional immune cells residing in the lamina 
propria could ‘overreact’ to increased antigen concentration, so IgA-bound pIgR and pIgR alone 
shuttle deleterious antigens back into the intestinal lumen (111-113).  Figure 1.1h shows the 
transepithelial shuttling of pIgR and IgA into the mucus layer in addition to immune functions 
provided by these proteins.  Section (a) displays immune exclusion to the mucus layer while (b) 
shows intracellular neutralization of virions and (c) intracellular neutralization of MAMPs plus 
prevention of NF-κB signaling; (d) illustrates antigen secretion back into the intestinal lumen.                      
 
Antimicrobial peptides  
 The diverse collection of antimicrobial peptides (AMPs) is used by the host in both the 
oral and intestinal epithelium, and many of the exact same peptides are used at both locations.  
Many of these molecules can be produced by all epithelial cell types, but the small intestinal 
Paneth cells are apparently differentiated to perform only this function (33).  Many types of 
immune cells also have the capacity for AMP production.  At the broad classification level, 
mucosal AMPs can be partitioned into one of seven groups: defensins, cathlecidins, angiogenins, 
lectins, lysozymes, collectins, and histatins (33).  This is not an exhaustive list, as novel peptides 
with antibacterial activity are being discovered at a consistent rate (114).  Most of these small 
molecules are amphipathic and carry a positive charge at physiological pH, which allows them to 
integrate into and disrupt bacterial membranes (115).  Within the defensin family, the β-defensins 
are found to be produced by epithelial surfaces and are especially prevalent within both the oral 
and intestinal mucosa (116).  The α-defensins are produced by neutrophils and Paneth cells, so 
these proteins are at considerably greater expression in the small intestine.  Cathlecidins, 
lysozymes, and histatins are readily found in both the oral cavity and intestinal lumen (33).  Due 
to the greater bacterial challenge faced along the intestinal tract, additional AMPs within the 
clusters of lectins (RegIIIα,β,γ), collectins, and angiogenins are also found in the small and large 
intestines.  Where an established mucus layer exists, AMPs are arranged much like fruit pieces in 
a Jell-O salad.  The inner mucus layer holds the greatest density of these peptides which aid to 
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inhibit bacterial survival and growth in this region and, ultimately, keep the microbiota separated 
from the epithelium (117). 
 
Hormones and their receptors 
Though numerous hormones are produced by the human host, research considering 
hormone activity in the relationship between host and microbe has generally been limited to 
metabolic proprieties.  It is well known bacterial products such as SCFAs and TLR ligands are 
able to impact production of and efficacy of appetite hormones such as leptin and ghrelin (118, 
119).  The adipokine adiponectin modulates inflammatory signaling pathways in numerous cell 
types, including: monocytes/macrophages (120, 121), endothelial cells (122-124), myocytes (125-
127), synovial fibroblasts (128), and intestinal epithelial cells (129).  Various cell models have 
shown that adiponectin has the capacity to modulate intracellular signaling through the NF-κB 
pathway (120, 127, 128) which is also utilized by all plasma membrane-bound TLRs (130).    
The receptors for adiponectin, AdipoR1 and 2, have been found on the epithelium of the 
oral (131), gastric (132, 133), and intestinal (134-136) surfaces. In particular, the oral and 
intestinal epithelial surfaces are in constant interaction with adiponectin as supplied through 
saliva (137, 138) and intestinal cells (139, 140), respectively. Furthermore, it is possible that 
adiponectin reaches epithelial cells through serum outflow from the surrounding 
microvasculature. Mice unable to produce adiponectin show worse response to colitogenic (141, 
142) and carcinogenic (136, 143, 144) conditions, leading to the paradigm that adiponectin helps 
the epithelium mitigate excessive inflammatory signaling that may be caused by the local 
microbiota (Chapter 3). 
 
D. CAUSES AND EFFECTS OF GI DYSBIOSIS AND INFLAMMATORY DISORDERS  
 
Dysbiosis overview 
With the discovery of microbes inhabiting all human mucosal surfaces and providing 
services the host genome is unable to generate, the fusion between the host and its microbiota is 
currently referred to as a superorganism (8).  In addition, the body’s microbial inhabitants contain 
genomes that collectively are thought to contain between 10 and 60 million unique genes (145, 
146), at least a 1000-fold greater amount than the human genome.  Integration of functions 
performed by the host and microbial genomes creates a ‘metagenome’ which is the synthesis of 
the host’s mutualistic relationship with resident microbes.  The overarching goal of the Human 
Microbiome Project is to “understand the range of human genetic and physiological diversity” 
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(8), which extends well beyond host genome. Currently, the idea of what it means for the 
microbiota to be ‘normal’ is subjective based upon the defining criteria of what a normal or 
healthy human is.  One strategy the Human Microbiome Project has employed to reduce 
variability is the characterization of microbiome communities at specific locations (e.g. 
subgingival plaque, nasal airway, stool) and then relating microbiotas to clinical data (145).  The 
goal is an elucidation of a ‘core microbiota’ at each of these sites which is common among all 
humans regardless of geographical location, dietary habits, or any other variable (8).  For our 
purposes, two types of dysbiosis will be discussed in this document: 1) the development and 
persistence of an abnormal microbiota, 2) the perturbation of the microbial community associated 
with a host action or disease state.          
 The evolutionary journey arriving at Homo sapiens has experienced the host-microbe 
relationship for hundreds of millions of years, and both participants are well-evolved to tolerate 
the other.  Appropriate maturation of the mammalian immune system is dependent upon presence 
of the GI microbiota (147-149), and studies in germ-free mice (150) and pigs (151) have shown a 
plethora of immune abnormalities during the animals’ development.  Two of the most striking 
features germ-free animals display is a stark reduction in number of B cells which have matured 
to immunoglobulin-secreting plasma cells and the increased susceptibility to challenges with 
bacteria and viruses, most of which would be innocuous to animals reared under microbial 
exposure.  Though humanity has been unsuccessful creating the germ-free person, the widespread 
adoption of the Westernized lifestyle has decreased both microbial exposure and the diversity of 
the individual microbiota (152, 153).  Concurrently, the prevalence of many allergic and 
autoimmune diseases is dramatically increasing in the Western world (154).  The first to receive 
credit for attempting to associate these two trends was David Strachan who, in 1989, proposed the 
pronounced increase in hay fever cases among wealthy children in Great Britain was due to 
“declining family size, improvements in household amenities, and higher standards of personal 
cleanliness” (155).  This now-termed Hygiene Hypothesis of a reduced antigenic environment 
during immune system development helps explain the rise of  many allergic, asthmatic, 
autoimmune , and metabolic diseases (152).   
 In most inflammatory disorders along the GI tract, no single bacterium can fulfill all of 
Koch’s postulates.  While Porphyromonas gingivalis inoculation has certainly been implicated in 
the progression of periodontitis (156), most, but not all, humans with the disease carry the germ 
in their oral cavity (157).  Likewise, the search for the microbial agent causing Crohn’s Disease 
(also, CD) was initially thought to be over with the finding of Mycobacterium avium subspecies 
paratuberculosis in CD patients (158).  However, since the initial finding, high-throughput 
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genetic analysis of thousands of intestinal bacterial communities has shown not all CD patients 
harbor M. avium (159, 160), and more broad groups of bacteria are now thought to play an 
etiological role (161).  With the aid of sequencing and microarray tools which allow a complete 
survey of the microbiome at a certain mucosal site, broad community dysbiosis is the 
contemporary paradigm for many human inflammatory diseases with known microbial 
components (162).  A diverse array of human diseases are known to be associated with dysboises: 
periodontitis, cystic fibrosis, celiac disease, inflammatory bowel disease, Type I diabetes, 
metabolic syndrome, psoriasis, esophageal disease, vaginosis, and irritable bowel syndrome 
(159).  The etiological significance of these dysbiotic states is hard to interpret, since the change 
in bacterial community may be inciting the disease or simply a result of the disease state.  Instead 
of drawing a straight line between a microbiota and a disease, more integrative approaches are 
being adopted to help explain the significance of a dysbiosis in the context of host phenotype and 
disease.  Figure 1.1i illustrates an example of a structural equations model which accounts for 
host genotype and covariates, gene and protein expression, physiological measurements, and 
microbiome composition as all contributors to host phenotype.   
  
Periodontitis  
 Damage and loss of the tissue surrounding the tooth are the hallmarks of periodontal 
disease, and clear microbial components have been identified.  The bacteria P. gingivalis, A. 
actinomycetemcomitans, Tannerella forsythia, and Treponema denticola are all associated with 
patients with progressive periodontal disease (157).  At a community level, gingivitis and 
periodontitis show a strong dysbiosis with decreases in Gram (+) bacteria such as the mutualists 
Streptococcus and Actinomyces but increases in Gram (-) rods (163).  Increases in the amounts of 
Gram (-) bacteria provide higher concentrations of LPS capable of stimulating TLR4 on the 
gingival epithelium and on immune cells directly beneath the squamous epithelium.  The 
pathogen P. gingivalis is known to modulate its own gene expression in order to more easily 
integrate into oral biofilms and persist in the mouth (164).  By its own association into dental 
biofilms, P. gingivalis likely evicts mutualists which are unable to compete with the pathogen. 
 
Obesity                                          
    With the rise of obesity and closely-associated metabolic syndrome in developed 
countries, the elucidation of the intestinal microbiota from affected individuals has shown 
pronounced insights about the disease.  Obesity-induced dysbiosis appears to be a causative and 
resulting factor linked to the disease.  Studies from the Jeffery Gordon lab have shown a clear 
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positive correlation between an individual’s body mass index (BMI) and percentage of intestinal 
bacteria within the phylum Firmicutes.  The group went on to show that as a person’s BMI 
decreases over time, the relative percentage of Firmicutes decreases while Bacteroidetes rises 
closer to that seen in lean individuals (165).  Other studies show overall decreased phylogenetic 
diversity of the intestinal microbiota in conjecture with obesity and increased bacterial gene 
expression of proteins involved in carbohydrate, lipid, and amino-acid metabolism (166).  This 
obese microbiota is transmissible in the mouse model, as shown when germ-free mice that 
received stool pellets from obese, but not lean, mice also displayed symptoms of obesity (167).  
Persons with hypertrophied adipose tissue are thought to be in a state of chronic low-grade 
inflammation, and are over-represented in IBD and colorectal cancer patient populations (168).  
In addition, circulating levels of the hormone adiponectin negatively correlating with BMI may 
play a role in promoting a more inflammatory environment (169).   
  
Inflammatory bowel diseases                   
 The two classical IBDs are designated as Crohn’s Disease (also, CD) and ulcerative 
colitis (UC).  The presentation of CD is generally found in the distal ileum and along multiple 
sites in the colon, showing a characteristic ‘skip lesion’ pattern of multiple sites of transmural 
inflammation (170).  More superficial inflammation is seen in UC, with disease severity 
increasing towards the distal colon in parallel with increasing amounts of intestinal bacteria (9).  
Both diseases show a skewing of T cell populations toward a Th1 and Th17 pro-inflammatory 
phenotype with reductions in the prevalence of T regulatory (Treg) cells (171).  With the advent 
of genome-wide association studies (GWAS), high-throughput profiling of intestinal microbiota, 
and elucidation of patient covariates which increase IBD susceptibility, the realm of IBD etiology 
is thought to be extremely multifactorial with multiple factors likely synergizing to cause a 
disease state (171).  Figure 1.1j illustrates the multifactorial nature of IBDs with many of the 
factors which are currently thought to play a role in patient susceptibility to the disease. 
   An individual’s genome or patterns of gene expression may increase IBD vulnerability 
through excessive responses to intestinal bacteria, inability to detect intestinal bacteria, 
breakdown of intestinal epithelial cell physiology and barrier function, or disruption of many 
other biological roles which maintain intestinal homeostasis (172).  Currently, GWAS have 
shown CD susceptibility loci to be generally within the categories of cellular innate immunity and 
other immune-mediated functions (173).  Likewise, UC susceptibility loci show many hits for 
immune-mediated functions, but gene mutations leading to defects in the epithelial barrier are 
also enriched in UC patients.  This notion is logical that disruption of any number of diverse 
18 
 
biological functions at the intestinal epithelium may predispose the host to reoccurring excessive 
inflammation.  With the incessant microbial challenge the ileum and colon must continually 
endure, the absence of any of the numerous homeostatic mechanisms employed by the intestine 
may tip the balance in favor of war with the intestinal microbiota as opposed to mutualistic peace 
(174).   
 As with dysbiosis in obesity, evidence exists for intestinal microbiota dysbiosis both 
playing a causative role in IBD and a result of IBD activity.  Transmissible UC mediated by the 
microbiota was found in studies using genetically susceptible mice (175), and animals infected 
with adherent-invasive bacteria within the family Enterobacteriaceae progress to a disease state 
mimicking IBDs (176, 177).  However, adherent-invasive bacteria are not always found in 
humans with IBDs (178), and host-mediated inflammation can also incite a state of dysbiosis 
(179).  At the perspective of the bacterial community, IBD presence shows a reliable decrease in 
the diversity and amount of microbes residing in the intestine (180, 181).  Bacteria within the 
phyla Firmicutes and Bacteroidetes show strong reductions while the Enterobacteriaceae family 
consistently increases in relative percentage of the total microbiota (41, 171).  These changes in 
composition also point to another advantage given to the host by the mutualistic microbiota: 
colonization resistance.  Resident microbes are able to fill ecological niches and secrete metabolic 
products that make colonization of new bacteria extremely difficult (32).  The enteric pathogen 
Salmonella enterica decreases colonization resistance through promotion of host inflammatory 
responses which will kill numerous mutualists (182).  This may be a strategy also used by 
bacteria associated with IBD in order to give themselves a colonization advantage.                                  
 
The mouse as a model to study human intestinal diseases 
 Both morphological and immunological differences exist between man and the laboratory 
mouse (183), but the mouse has nevertheless become an important model in the pursuit of 
information about human intestinal diseases.  Advantages include reduction of genetic variability 
through inbreeding and the fast generation of experimental subjects.  Laboratory mice also have a 
very similar intestinal microbta to humans with major variations only arising at the family and 
lower taxanomic levels (184).  However, many types of mouse immune and epithelial cells 
produce different cytokines and express different cell surface proteins as well as mouse B cells 
repertoires having different IgG and IgA subtypes (183).  Also, to ensure mice are not 
unintentionally exposed to pathogens, animals are housed under sterile conditions where water, 
food, and bedding are all disinfected which is not representative of our microbial-painted world.  
One of the most powerful tools at the researcher’s disposal is the knockout (KO) mouse, which 
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cannot produce protein(s) of interest due to genetic alterations.  Many transgenic mice develop 
spontaneous inflammation in the intestine, and include mice unable to produce immunoregulatory 
proteins such as IL-10 and TGF-β, barrier regulation proteins WASP and N-cadherin, mucus 
proteins muc2 and trefoil factor, and inhibitors of NF-κB signaling A20 and IKKγ (185).  
Intestinal inflammation in almost all of these transgenic mice is microbial-mediated and shown to 
be ameliorated when the mice are raised under germ-free conditions (150).  Mice can also be 
subjected to chemically-induced colitis, the most common form being supplementation of dextran 
sulfate sodium (DSS) in animal’s drinking water which mimics the increased inflammation in the 
distal colon as seen in UC (186).  Overall, though clear differences exists between mouse and 
human immunity, the mouse model provides researchers with an effective tool to study causes 
and effects of inflammation in the intestine its resident microbiota.                
 
E. SCOPE AND SIGNIFICANCE OF THIS DISSERTATION  
 This dissertation further illuminates many of the sophisticated languages used by host and 
bacterium in order to maintain an environment which is beneficial for both parties.  For all 
studies, the oral or intestinal epithelium is the central focus of the work.  In Chapter 3, the first 
language discussed is how the hormone adiponectin modulates oral microbial TLR ligand and 
host TNF signaling to and cause dramatic changes in oral and colonic epithelial cell gene 
expression and cytokine production as well as changes in the NF-κB signaling cascade.  Chapter 
4 demonstrates how intestinal bacteria only within certain phyla are able to induce colonic 
epithelial cell (also, CEC) gene expression of pIgR and other microbial response genes.  This 
study further shows the polarized nature of CEC stimulation gene expression dynamics over 
periods of extended stimulation.  In addition, this chapter shows the localization of SIgA and SC 
in the outer mucus layer of the colon in both mice and humans and that intestinal bacteria localize 
with these proteins in the outer mucus layer.  Chapter 5 shows the impact of SIgA within 
maternal milk on the establishment of the intestinal microbiota and CEC gene expression in adult 
mice.  Interestingly, very specific genotypic and phenotypic differences were seen between mice 
receiving maternal IgA, but not SIgA, and mice receiving only IgA were in an 
immunocompromised state early and later in life, well after dissociation from their mothers.  
Collectively, these studies help shed further light on the complex relationship between the host 
and its microbiome and the necessity for multiple mechanisms to ensure mutualism.                        
 
 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1a [Adapted from Ref. (12) with permission].  Structure of stratified squamous oral 
epithelium showing multi-layered epithelial cells overlying fibroblasts and macrophages.     
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Figure 1.1b [Adapted from Ref. (187)].  Hematoxylin and eosin stain of oral gingival biopsy 
showing clear stratified nature of the epithelium and distinct transition from epithelial cells to 
fibroblasts.   
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Figure 1.1c [Adapted from Ref. (18) reprinted with permission from AAAS].  Architecture of 
small intestinal epithelium showing villus/crypt axis and stem cell maturation into one of four 
intestinal epithelial cells (IECs).  IECs life span is thought to be less than five days from nascent 
differentiation to shedding into the intestinal lumen, so consistent replenishment of these cells is 
required by the host.          
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Figure 1.1d [Adapted from Ref. (19) reprinted with permission].  Small intestinal architecture 
and cell types. a) Hematoxylin and eosin stain of mouse small intestinal biopsy showing stricture 
of villus and crypt.  b) goblet cells along the vilus stained positive for mucus with periodic acid-
Schiff, c) an enteroendocrine cell stained positive for synaptophysin, d) paneth cells stained 
positive for lysozyme, e) and absorptive enterocytes stained positive with alkaline phosphatase.       
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Figure 1.1e [Adapted from Ref. (149) reprinted with permission].  Structure of large intestinal 
epithelium and organized mucus layers.  Goblet cells along large intestinal epithelium secrete 
mucus into intestinal lumen, forming two distinct layers.  Bacteria are segregated largely to outer 
mucus layer while host antimicrobial proteins from epithelial cells and IgA from lamina propria 
plasma cells are found throughout mucus layer.       
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Figure 1.1f [Adapted from Ref. (188)].  H&E-stain section of mouse colon showing deep crypt 
penetration into the lamina propria, goblet cell size and localization in situ, and secreted mucus 
filling crypt crevasses and migrating to luminal space.  Once in the luminal space, mucus remains 
adhered to colonic epithelium and forms an organized layer.        
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Figure 1.1g [Adapted from Ref. (9) reprinted with permission].  Microbial recognition by 
epithelial cells.  Membrane bound and intracellular Toll-like receptors (TLRs) as well as the Nod-
like receptors NOD 1 and 2 are shown in situ with their respective microbial ligands.  All TLRs 
(except TLR3) signal through the MyD88 adaptor protein to activate the mitogen-activated 
protein kinase (MAPK) and NF-κB cascades and induce host response and gene expression.  
NOD receptors utilize the adaptor protein RICK to signal through NF-κB, but are also able to 
signal through the MAPK pathway.  The inhibitors of signal transduction, Tollip and A20, are 
shown at which steps in the pathway they disrupt.           
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Figure 1.1h [Adapted from Ref. (105) reprinted with permission].  Mechanism of transport and 
functions for polymeric IgA and polymeric immunoglobulin receptor (pIgR/SC) at the epithelial 
surface.  Production of IgA and J chain by IgA+ plasma cells allows the efficient multimerization 
of IgA proteins with connecting J chain.  Polymerized IgA then binds pIgR on the basolateral 
surface of the epithelial cell and is transported through endosomal vesicles to the apical surface of 
the cell where it is cleaved and released (now SIgA) into the mucus layer.  Multiple immune 
functions are mediated by the SIgA and SC proteins.  Section (a) displays immune exclusion of 
antigens (Ag) to the mucus layer while (b) shows intracellular neutralization of virions and (c) 
intracellular neutralization of microbial products plus prevention of NF-κB signaling; (d) 
illustrates antigen secretion back into the intestinal lumen. 
 
28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1i [Adapted from Ref (159) reprinted with permission].  A comprehensive structural 
equations modeling (also, SEM) approach to link host variables (with certain emphasis on host 
microbiome) with host phenotype.  Collectively, the red and blue connectors (nodes) forms a set 
of interrelated regression equations with random independent as well as dependent variables that 
allow formulation and testing of directional causal pathway hypotheses (189).  The path 
coefficients α,β,γ,etc. are regression coefficients of each nodal regression equation which can be 
analyzed individually.  However, the optimal resolution for the host in a clinical setting is the 
simultaneous analysis of the entire equations system.  The host microbiome can be sampled by 
various sequencing techniques, some of which include: Sanger sequencing (Y1), 454 
pyrosequencing of V1 and V3 regions of bacterial 16S rRNA (Y2), pyrosequencing of V3 and V5 
regions (Y3), and quantitative PCR (Y4).             
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Figure 1.1j [Adapted from Ref (190) reprinted with permission].  The multifactorial nature of 
chronic inflammatory bowel disease (IBD).  IBDs may present and persist by the overlap of any 
or all of these susceptibility factors.  Mutations in genes allowing for control of intestinal 
epithelial barrier integrity, killing of bacteria in close contact with the epithelium, or regulation of 
host immune response increase likelihood of IBD, but are probably not enough in themselves to 
incite disease.  A common finding among IBD patients is the increased skewing of T cell subsets 
towards the Th1 and Th17 pro-inflammatory lineages which overact to innocuous intestinal 
microbes.  Multiple environmental factors have been implicated in IBD occurrence, and include 
many practices associated with the Westernized lifestyle.  Consistent trends are seen in IBD 
patients with or without active disease by dysbiosis of intestinal microbiota with increases in 
relative percentage of facultative aerobic species within the family Enterobacteriaceae and broad 
decreases in amounts and percentages of the Firmicutes and Bacteroidetes phyla.       
Copyright © Eric William Rogier 2012 
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Chapter 2 
MATERIALS AND METHODS  
 
Collection of tissue biopsies from human subjects (Chapter 3,4). Adult volunteers (age 18-80) 
for these studies were recruited from patients undergoing colonoscopy at the University of 
Kentucky Medical Center, after institutional review board approval and written informed consent. 
For patients with inflammatory bowel disease (IBD), including Crohn’s disease (191) or 
ulcerative colitis (UC), the indication for colonoscopy was either to evaluate disease exacerbation 
or to screen for dysplasia and colorectal cancer. Diagnosis of IBD was based on clinical, 
radiological and endoscopic criteria and supported by histopathological findings.  Control 
subjects age 50 or older underwent screening colonoscopies for colon cancer in accordance with 
current guidelines. Control subjects age 18-49 underwent colonoscopy for evaluation of 
constipation or chronic abdominal pain. Individuals were classified as “normal” when 
endoscopic, radiologic and pathologic evaluation of randomly obtained biopsies revealed no 
disease of the small or large bowel. ‘Healthy’ (control) subjects defined by the absence of CD, 
UC, indeterminate colitis, or celiac disease at any time in their life.  Mucosal biopsies were 
collected from the terminal ileum and pooled from multiple locations in the ascending, transverse 
and descending colon. Subjects who consented to participate in the study subsequently underwent 
periodontal examination at the University of Kentucky College of Dentistry, and biopsies were 
obtained from regions of the gingiva without macroscopic inflammation. Biopsied tissue was 
immediately immersed in an RNA stabilizing solution (RNAlater) (Qiagen, Valencia, CA), and 
stored at -80°C.  Gene expression analysis of gingival biopsies only preformed on patients 
without intestinal inflammation.   
 
Mice (Chapter 4,5). Male and female wild-type C57BL/6 mice were obtained from ongoing 
mouse colony under the supervision of Dr. Charlotte Kaetzel at the University of Kentucky which 
had originally been purchased from The Jackson Laboratory (Bar Harbor, ME).  Transgenic mice 
with NeoR cassette inserted into exon 3 of mouse PIGR locus and unable to produce functional 
Pigr protein were initially created as described previously (75) and were a kind gift from Dr. 
Finn-Eirik Johansen, University of Oslo, Norway.  Mucin 2 (Muc2) deficient mice which had 
initially been created by replacing of exons 2-4 in Muc2 gene with PKG-Neo cassette (88) were a 
kind gift from Dr. Anna Velcich, Albert Einstein College of Medicine, New York, NY.  All mice 
were bred in the animal facility at the University of Kentucky College of Medicine. All mice 
were kept in microisolator cages with sterile bedding and were fed sterile food and water.  For 
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experiments utilizing the maternal milk breeding scheme (Figure 5.1A), mice were separated by 
gender and Pigr genotype at the time of weaning for the duration of their lives.  Mice were 
maintained and used in accordance with the policies and guidelines set forth by the University of 
Kentucky Institutional Animal Care and Use Committee. 
 
Eukaryotic cell culture (Chapter 3,4).  The HT-29v20 subclone of the human colon 
adenocarcinoma cell-line HT-29 (192) and the human acute myeloid leukemia cell line THP-1 
(193) (a generous gift of Dr. Sarah D’Orazio, University of Kentucky) were cultured in DMEM 
Ham’s F-12 (1:1) media supplemented with 5% fetal bovine serum and antibiotics (100 U/ml 
penicillin, 100 µg/ml streptomycin and 250 ng/ml fungizone) – collectively, ‘Complete Medium’.  
The immortalized human oral keratinocyte OKF6/hTERT-2 (194) cell-line, which has normal 
growth and differentiation characteristics that represent a model of oral epithelium (195), was 
cultured in serum-free keratinocyte medium as previously described (196).  All cell lines were 
grown at at 37°C and 5% CO2. All cell culture reagents were from Lonza Walkersville 
(Walkersville, MD) or Invitrogen Life Technologies (Carlsbad, CA). For experiments with 
bacterial stimulation (Chapter 4), HT-29 cells were plated in 24-well dishes or Transwell inserts 
and grown for 24-48 h to a density of approximately 106 cells/well prior to initiation of 
experiments. THP-1 cells were maintained in suspension culture, and were diluted to a density of 
1x106 cells/well in 24-well dishes immediately before exposure to bacteria. Heat-killed or live 
bacteria were diluted to a final concentration of approximately 107 cells/well.  For adiponectin 
stimulation experiments (Chapter 3), OKF6 and HT-29 cells were grown to approximately 70% 
confluence, then treated as described in the figure legends. Recombinant high molecular weight 
human adiponectin (HMWAd) produced in HEK293 cells, which mimics serum adiponectin by 
forming high molecular weight (HMW) and hexameric species, was obtained from Enzo Life 
Sciences, Farmingdale, NY. Recombinant human TNF, produced in E. coli, was obtained from 
eBioscience, San Diego, CA.  The LPS purified from E. coli O26:B6 was obtained from Sigma-
Aldrich, St. Louis, MO, and recombinant flagellin from Salmonella typhimurium was obtained 
from InvivoGen, San Diego, CA.  At the termination of all cell culture experiments, culture 
supernatants were collected and stored at -20oC for cytokine analyses, and cells were harvested in 
buffer RLT and stored at -20oC for RNA purification. 
  
Bacterial cell culture (Chapter 4).  Escherichia coli Nissle 1917 was the generous gift of Dr. 
Ulrich Sonnenborn, Ardeypharm GmbH, Herdecke, Germany. Salmonella typhimurium SL1344 
was the generous gift of Dr. Sarah D’Orazio, University of Kentucky. All other bacteria were 
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obtained from the American Type Culture Collection (Manassas, VA). Prior to incubation with 
eukaryotic cells, bacteria were grown to mid-log phase in Schaedler broth (Oxoid, LTD, 
Basingstoke, UK) under anaerobic conditions at 37oC. For quality control, the identity of each 
bacterial species was confirmed by PCR amplification of the 16S rRNA gene with species-
specific primers. Heat-killed bacteria were prepared by diluting liquid cultures to approximately 
108 colony-forming units (CFU)/ml in eukaryotic tissue culture medium and heating at 65oC for 
30 min. Aliquots of bacterial cultures prior to heat treatment were plated on Schaedler agar to 
quantify CFU. For experiments with live bacteria, aliquots of bacterial suspensions before and 
after co-culture with eukaryotic cells were plated on Schaedler agar to quantify CFU. 
 
In vitro bacterial invasion assay and FITC dextran flux (Chapter 4).  The ability of live E. 
coli Nissle or S. typhimurium SL1344 to invade monolayers of HT-29 cells was analyzed as 
described (197). Approximately 107 bacteria were added to 24-well dishes containing 
approximately 106 HT-29 cells. After 1 h, triplicate cultures of HT-29 cells were washed 
extensively with Hank’s Balanced Salt Solution (HBSS), lysed with 1% Triton X-100, and plated 
on Schaedler agar to enumerate total cell-associated CFU. Separate triplicate cultures of HT-29 
cells were treated with gentamicin (480 µg/ml in HBSS) for 90 min at 37oC to kill bacteria bound 
to the external cell surface, washed extensively, lysed, and plated on Schaedler agar to enumerate 
internalized CFU. Membrane-associated bacteria were calculated by subtracting internalized CFU 
from total cell-associated CFU.  Permeability across epithelial monolayers measured by adding 
5mg/mL 3kD FITC-dextran (Sigma) to Transwell apical chamber and collecting well basal 
chamber volume after 3h and reading flow-through FITC concentration by spectrophotometer.  
Flux across HT-29 monolayer measured by: [ug FITC-dextran in basal chamber / time (in 
seconds)].  
 
NF-κB reporter assay (Chapter 3). HT-29 cells incubated in serum-free medium 19h after 
transfection for 6h. Cells pretreated with HMW adiponectin for 18h and subsequent 6h TLR 
ligand or TNF stimulation. Cell lysates were analyzed for firefly and Renilla luciferase activities 
using the Dual Luciferase Reporter Assay System (Promega). NF-κB enhancer activity was 
calculated by subtracting the normalized luciferase activity of cells treated with pTK-luc from the 
normalized luciferase activity of cells treated with pNF-κB-TK-luc.  
 
DSS colitis regimen (Chapter 5). Acute colitis induced in mice by feeding of 2% dextran 
sodium sulfate (DSS, MP Biomedicals, Aurora, OH) in drinking water for 8 days.  Mice were 
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weighed every day of treatment and surveyed for stool consistency and occult or visible blood for 
calculation of disease activity index (also, DAI) by summation of scores from all three 
parameters.  On day 9 of the treatment regimen mice were sacrificed, colons were extracted and 
measured, and tissue fixed for histology or processed for epithelial cell isolation.     
   
Isolation of bacteria from mesenteric lymph nodes and identification of prominent aerobic 
species (Chapter 5).  Mesenteric lymph node (MLN) sections surrounding the cecum were 
dissected from 21d old mice under sterile conditions, homogenized in sterile PBS, and cultured 
on Schaedler agar plates under both aerobic and anaerobic conditions.  To identify the prominent 
aerobic bacteria found in weanlings not receiving SIgA, 2 colonies derived from two different 
mouse MLNs were harvested and cultured overnight in Schaedler broth at 37o under aerobic 
conditions. Bacterial DNA was extracted by QIAamp DNA Stool Isolation Kit (Qiagen, 
Germantown, MD), and the 16S rRNA gene was amplified by real-time PCR using the universal 
Eub primers (198). The PCR products were ligated into the pGEM-T vector (Promega, Madison, 
WI), then used to transform frozen competent E. coli DH5α (Promega) to ampicillin resistance 
using standard protocols. Two ampicillin-resistant colonies were harvested and cultured in LB 
broth containing 100µg/ml ampicillin. Bacterial DNA was purified using the Qiagen miniprep kit 
(Qiagen), and shipped to ACGT, Inc. (Wheeling, IL) for sequence analysis. Identical sequences 
of the unknown 16S rRNA were compared with the sequences of known bacterial genomes by 
BLAST analysis of the National Center for Biotechnology Information database  
(http://blast.ncbi.nlm.nih.gov/Blast).  
 
Fixation and rehydration of tissues and histological scoring of colons (Chapter 4,5). Colons 
were dissected from euthanized mice and fixed in formalin, Carnoy’s fixative (all figures of 
colons), or prepared for epithelial cell isolation.  Fixed tissues were embedded in paraffin and 
sectioned onto glass slides.  Tissue sections were dewaxed in xylene and rehydrated by ethanol 
gradient by previous protocol (186).  For histological scoring, rehydrated colonic sections were 
stained with H&E to visualize colonic attributes and morphology and allow scoring.  Scoring was 
performed in a blinded fashion with possible score from 0-4 for each of four sites along colonic 
length scored (total possible score of 16  indicating most severe disease). 
    
Epithelial cell isolation from mouse colons (Chapter 5).  Epithelial cells from colonic tissue 
were isolated as previously described (186, 199). Colons were opened longitudinally, cut into 
small pieces, and the mucus layer was removed by incubation for 20 min with agitation at 37°C 
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in a solution of 1mM dithiothreitol (Sigma, St. Louis MO) in Complete Medium. The 
supernatants were discarded, and the epithelium was stripped from the tissue pieces by incubation 
for 1 h at 37°C in a solution of 0.5 M EDTA in Complete Medium. The suspension was vortexed, 
supernatant containing epithelial cells was poured off. Isolation of epithelial cells was 
accomplished by resuspension of the cell pellets in a 10 ml solution of 30% w/v Percoll (Sigma) 
and centrifugation at 1300 rpm for 20 min at room temperature. The top layer containing floating 
epithelial cells was removed and transferred into a 15 ml conical tube. The volume was brought 
to 10 ml with supplemented tissue culture medium, and epithelial cells pelleted by centrifugation 
at 2000 rpm for 10 min at 4°C and resuspended in buffer RLT.  
 
Immunofluorescence of in vitro cell lines (Chapter 3). For p65 (RelA) staining on cell lines, 
cells were grown on glass 8-Chamber Slide system (Lab-Tek, Naperville, IL) and fixed with 4% 
paraformaldehyde for 10min and subjected to additional permeabilization in methanol for 15min 
at -20o after fixing. Slides were mounted with mounting medium containing DAPI (Vectashield, 
Burlingame, CA). Permeabilized cells stained for p65 localization to the nucleus as described 
previously (58) with rabbit anti-p65 (1:100, Santa Cruz) overnight at 4o and sheep anti-rabbit IgG 
(1:200, Sigma-Aldrich) 1h at room temperature. Images taken using a Zeiss Axiophoto confocal 
microscope with Axiovision image software. 
 
Immunofluorescence staining and tissue microscopy (Chapter 4,5). After dewaxing and 
rehydration of tissue slides, antigen retrieval was performed by incubating slides for 20 min at 
95°C in 25 ml of 10mM sodium citrate buffer, pH 6.  For only slides undergoing pIgR/SC 
staining, endogenous peroxidase activity was quenched by incubation for 10 min at room 
temperature in 25 ml of 3% (v/v) H202.  Rehydrated slides blocked for 30min in PBS containing 
0.1% TritonX-100 and 10% serum from secondary antibody species.  Primary antibodies kept on 
slides overnight after dilution in blocking buffer at concentrations: pIgR/SC 1:250 (produced in 
goat, R&D Systems), muc2 1:100 (produced in rabbit, Santa Cruz).  Secondary antibodies diluted 
in blocking buffer and kept on slides for 2h at room temperature at concentrations: pIgR/SC 
1:500 (HRP-rabbitαgoat IgG, Invitrogen), muc2 1:200 (Rhodamine bovineαrabbit IgG, Santa 
Cruz), IgA 1:200 (FITC, goatαmouse IgA, Santa Cruz) . To visualize pIgR/SC protein, bound 
peroxidase was revealed with TSA Plus-TMR Reagent (Perkin-Elmer, Waltham MA). To 
visualize nuclei, sections were counterstained with VectaShield containing DAPI. Imaging was 
performed on a Zeiss Axiophoto confocal microscope with Axiovision image software. 
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Fluorescence in situ hybridization (Chapter 4,5).  After rehydration, tissue slides were probed 
for bacteria as previously described (36).  Briefly, the Eub probe recognizing all bacteria (198) 
conjugated to Alexafluor647 fluorophore (Invitrogen) was diluted to 25ng/mL in hybridization 
buffer (20mM TrisHCl, 0.9M NaCl, 0.1%SDS, pH 7.4) and kept at 50oC overnight.  Slides were 
washed in 50oC wash buffer (hybridization buffer without SDS) for 20min, washed once more 
briefly, and mounted with VectaShield containing DAPI.   
     
mRNA analysis of cell culture lines for bacterial studies (Chapter 4).  Total cellular RNA was 
extracted from cell lines using the Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA). The quality 
of purified RNA was analyzed by agarose gel electrophoresis. cDNA was synthesized using 200-
300 ng of total cellular RNA and the TaqMan Gold RT-PCR kit with random hexamers (Applied 
Biosystems, Foster City, CA). Specific mRNA levels were quantified by real-time reverse 
transcriptase PCR (qRT-PCR), using the ABI Prism® 7700 Sequence Detection System (Applied 
Biosystems). The sequences of primers and fluorescent probes for the human genes pIgR, 
interleukin (IL)-8, tumor necrosis factor (TNF) and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) have previously been reported (200). The proprietary software PrimerExpress™ 
(Applied Biosystems) was used to design the primers and probe for mouse pIgR as follows (5’-
3’): forward primer: CTATTGGTGTCTTACCAATGGTGACT; reverse primer: 
CTGTTGCGTTCTGTGGCGT; TaqMan probe: ACAATAGAACTCCAGGTTGCCGAAGCT 
ACAAGG. Pre-designed primers and probes for A20 and MAPK phosphatase (MKP)-1 were 
purchased from Applied Biosystems. PCR was performed using 40ng reverse-transcribed RNA 
and TaqMan Universal PCR Master Mix, no UNG (Applied Biosystems). Amplification of the 
cDNA template was measured at every cycle by fluorescence resonance energy transfer (ΔRn). 
The threshold cycle (145), which is inversely proportional to the level of a given mRNA 
transcript, is defined as the cycle at which the ΔRn exceeds the threshold of fluorescence 
detection. To determine the relative level of target mRNA in individual samples, the CT values for 
each message were normalized to the CT for the control genes GAPDH (HT-29 and THP-1 cells) 
by the formula (2-(CTtarget-CTcontrol)) x 100%.  
 
mRNA analysis for adiponectin studies (Chapter 3).  Biopsies or cells in buffer RLT were 
lysed by MagNA Lyser (Roche, Basel Switzerland) and total RNA purified by MagNA Pure 
Compact RNA Isolation Kit (Roche) protocol with elution volume of 50μL. RNA quality and 
quantity were determined with a spectrophotometer (NanoDrop Technologices, Wilmington, DE). 
cDNA of purified RNA was synthesized using QuantiTect Reverse Transcription Kit (Qiagen). 
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Real-time quantitative RT-PCR of cDNA products performed by BioRad CFX96 Real-time 
System (BioRad, Hercules, CA) in Microseal low profile plates (BioRad). Primers (nucleotide 
sequence not provided) for β2 microglobulin (β2m), IL-8, TNF, A20, p65 (RelA), adiponectin 
receptor 1 (AdipoR1), AdipoR2, PPARγ purchased from SA Biosciences (Frederick, MD) and 
real-time cycles ran according to their protocol with RT2 Fast SYBR Green qPCR Master Mix 
(SA Biosciences). PCR specificities were confirmed by melting curve analysis of amplified gene 
products displaying single peak. mRNA levels normalized to MHC molecule β2 microglobulin 
present on all nucleated cells and quantified by ∆Ct method: [(2-(Ct test – Ct β2m)) x 100%]. 
 
mRNA analysis by microarray and Nanostring nCounterTM Hybridization (Chapter 5).  
Total RNA was purified from isolated CEC cells in buffer RLT by lysing on MagNA Lyser 
(Roche, Basel Switzerland) and total RNA purification by MagNA Pure Compact RNA Isolation 
Kit (Roche) according to their protocol with elution volume of 50μL. RNA quality and quantity 
were determined with a spectrophotometer (NanoDrop Technologices, Wilmington, DE).  
Microarray analysis was done using Affymetrix Mouse Gene 1.0 ST Array GeneChip according 
to their protocol (www.affymetrix.com).  For mRNA analysis using the Nanostring nCounterTM 
hybridization technique, colonic epithelial cells were isolated from freshly dissected colons as 
previously described (199).  Abundance of mRNA transcripts was analyzed by Nanostring 
nCounterTM hybridization (201), and normalized using an algorithm developed by NanoString, 
Inc. (www.nanostring.com). 
  
Biological pathway overrepresentation analysis of microarray gene expression data 
(Chapter 5).  Gene lists found to be significantly (p < 0.01) up- or downregulated from three 
experimental factors or combination of factors by microarray analysis (see Venn diagram, Fig. 
5.5A) were queried for biological pathway overrepresentation by Reactome database 
(www.reactome.org). Reactome is an open source database and website for the exploration and 
analysis of human biological pathways (202, 203). Reactome contains core datasets for systems 
biology. Pathways are built from biological reactions that are connected as steps in the pathway. 
Each reaction describes a biological event (e.g. binding, phosphorylation, transport, or enzymatic 
process) based on information provided by expert biologists, peer‐reviewed to ensure the 
resulting pathways represent the biological consensus. Every reaction is supported by published 
experimental data stored in bioinformatics databases, including: NCBI Entrez Gene, Ensembl, 
UniProt, UCSC and HapMap genome browsers, KEGG compound, ChEBI small molecule, 
PubMed, and Gene Ontology. Pathways are anthrocentric, but may incorporate data from model 
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organisms in the case of conserved functions, although these reactions are clearly differentiated 
from those that were experimentally determined in humans. Each topic is represented as a 
hierarchy of pathway diagrams.  Gene list overrepresentation of biological event at p < 0.01 
determined to be significant for this study.         
 
Cytokine quantification by electrochemical luminescence (ECL) (Chapter 3).  Cell 
supernatants were analyzed for pg/ml concentrations of IFNγ, IL-10, total IL-12, IL-13, IL-17, 
IL-1β, IL-8 (CXCL8), and TNF by Custom Human 10-spot ECL plate (Meso Scale Descovery, 
Gaithersburg, MD) according to their protocol.  
 
Analysis of IL8 from cell supernatants and fecal IgA by enzyme-linked immunosorbant 
assay (ELISA) (Chapter 4,5). Cell culture supernatants analyzed for IL8 protein levels as 
described by manufacture’s protocol (R&D systems, Minneapolis, MN).  In the same way, mouse 
feces were weighed, liquefied in ELISA dilution buffer, and analyzed by ELISA for total IgA 
(Bethyl Laboratories, Montgomery, TX).  For both ELISA kits, HRP substrate was bought from 
R&D systems.  Optical density (OD) measured by absorbance at 450nm on Spectramax M5 
(Molecular Devices, Sunnyvale, CA) and fitted to standard curve of known dilutions by SoftMax 
Pro software.   
 
Analysis of mouse fecal microbiota (Chapter 5). Bacterial DNA from mouse feces purified 
using QIAamp DNA Stool Isolation Kit according to manufacturer’s protocol (Qiagen).  For 
qRT-PCR analysis of bacteria, primers for 16S rRNA regions of intestinal bacteria were used as 
published previously (198) with iQ SYBR Green Supermix (Bio-Rad) after optimization by our 
lab.  Cycle threshold levels were determined on ABI Prism® 7700 Sequence Detection System.  
For phyochip analysis of fecal microbiota, samples were sent to Second Genome, Inc. (San 
Bruno, CA) for analysis by the PhyloChipTM microarray (204).  Bacterial 16S rRNA genes were 
amplified by PCR using the forward primer 5’-AGRGTTTGATCMTGGCTCAG-3’ and reverse 
primer 5’-GGTTACCTTGTTACGACTT-3’, fragmented, biotin labeled, and hybridized to the 
PhyloChip™ Array, version G3. Stained arrays were scanned with a GeneArray® scanner 
(Affymetrix), and analyzed by Affymetrix software (GeneChip® Microarray Analysis Suite). All 
profiles are inter-compared in a pair-wise fashion to determine a UniFrac distance metric, which 
utilizes the phylogenetic distance between OTUs to determine the dissimilarity between 
communities (205). For weighted UniFrac, (WuniFrac), both the abundance and dissimilarities 
among OTUs were considered. Phylogenic trees was generated using the “Interactive Tree of 
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Life” software tool (206). Principal Component Analysis (PCA) was used to position points on 
two-dimensional ordination plots based on dissimilarity values. Significant OTUs whose 
abundance characterizes each mouse genotype were identified by Prediction Analysis for 
Microarrays (PAM analysis), which utilizes a nearest shrunken centroid method (207). 
   
Statistical Analysis (Chapter 3). Statistical significance of differences in gene or protein 
expression among treatment groups was assessed by ANOVA and Fisher’s protected least 
significant difference test. Statistical significance of differences in gene expression between 
paired samples of non-inflamed and inflamed tissues from individual IBD patients was 
determined by non-parametric paired sign test. 
  
Statistical Analysis (Chapter 4).  Statistical differences among treatment groups were 
determined by ANOVA and Fisher’s protected least significant difference test. 
 
Statistical Analysis (Chapter 5).  Statistical differences among treatment groups for protein, 
IgA, bacterial abundance, and bacterial CFU amounts determined by ANOVA and Fisher’s 
protected least significant difference test.  Analysis of fecal microbiota at the population level 
included both statistical analysis of abundance and binary metrics at each taxa-sample 
intersection.  Sample-to-sample distance functions comparing dissimilarity between communities 
determined by the Unifrac distance metric (13) using unweighted (absence/presence) or weighted 
(+ abundance) considerations.  Two-dimensional ordinations and hierarchical clustering maps of 
the samples in the form of dendrograms were created to graphically summarize the inter-sample 
relationships. To create dendrograms, the samples from the distance matrix are clustered 
hierarchically using the average-neighbor (HC-AN) method. Principal Coordinate Analysis 
(PCoA) by two-dimensional ordination plotting used to visualize dissimilarity values to position 
sample points relative to each other. Lists of significant taxa whose abundance characterizes each 
class performed using Prediction Analysis for Microarrays (PAM) which utilizes a nearest 
shrunken centroid method (208).  The Adonis test utilized for finding significant whole 
microbiome differences among discrete categorical or continuous variables. In this 
randomization/monte carlo permutation test, the samples randomly reassigned to the various 
sample categories, and the mean normalized cross-category differences from each permutation 
are compared to the true cross-category differences. The fraction of permutations with greater 
distinction among categories (larger cross-category differences) than that observed with the non-
permuted data reported as the p value for the adonis test. For significance testing of paired sample 
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sets a paired Student’s t-tests was performed on abundance values of each OTU per paired sample 
(p-value threshold of 0.05 and 0.01).  For analysis of mRNA abundance, PCoA utilized to 
determine sample distribution and population clustering by two-dimensional plotting.  Analysis of 
Variance measurements calculated differences between sample populations with statistical 
significance determined at p < 0.05.                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Eric William Rogier 2012 
40 
 
Chapter 3 
HIGH MOLECULAR WEIGHT ADIPONECTIN MODULATES IMMUNE RESPONSES OF 
ORAL AND INTESTINAL EPITHELIAL CELLS THROUGH NF-κB-DEPENDENT TNF 
AND TOLL-LIKE RECEPTOR SIGNALING  
 
INTRODUCTION 
Adiponectin is the primary adipokine secreted by white adipose tissue in humans (209).  
Serum levels are variable, but tend to average in low μg/ml quantities with a range of 2-17μg/ml 
in a healthy individual (169) which inversely correlates with BMI (210-212).  By itself, full-
length adiponectin has been shown to be capable of signaling through various cell types in vitro 
and in vivo including: monocytes/macrophages (120, 121), endothelial cells (122-124), myocytes 
(125-127), synovial fibroblasts (128), and intestinal epithelial cells (129).  Globular adiponectin, 
which is a cleavage product of the full-length protein, appears to have high affinity for 
adiponectin receptor 1 (AdipoR1) and low affinity for adiponectin receptor 2 (AdipoR2) whereas 
full-length adiponectin employs the opposite scheme with high AdipoR2 and low AdipoR1 
affinity (213, 214).   
 Both AdipoR1 and 2 have been detected on the epithelium of the oral (131), gastric (132, 
133), and intestinal (134-136) surfaces.  In particular, the oral and intestinal epithelial surfaces are 
in constant interaction with adiponectin as supplied through saliva (137, 138) and intestinal cells 
(139, 140), respectively.  Furthermore, it is possible that adiponectin reaches epithelial cells 
through serum outflow from the surrounding microvasculature.  Data is limited, but AdipoR1 and 
2 expression appears to be downregulated in the gingiva during periodontal disease (131).  Full-
length adiponectin and the adiponectin receptors are expressed at lower levels in patients with 
gastric cancers (132, 133) and in mice subjected to DSS colitis (140), leading to the view that 
adiponectin acts in a protective, anti-inflammatory manner.  Furthermore in the mouse model, 
knockout of the adiponectin gene has been shown to worsen host response to colitogenic (141, 
142) and carcinogenic (136, 143, 144) conditions.  Conflicting reports have shown that 
adiponectin has no protective effect in preventing colitis or colorectal cancer, and may even 
worsen the condition (139, 215). 
In addition to the presence of adiponectin, the oral and intestinal epithelium are 
persistently exposed to exogenous antigens from the resident microbiota that signal to epithelial 
cells through pattern recognition receptors (PRRs) on the cell surface (216, 217).  Due to the 
continuous presence of bacterial products at the oral and intestinal interface, epithelial cells at 
these locations are required to respond in a subdued manner or the host will suffer acute 
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inflammation.  Toll-like receptors (TLRs) constitute the primary bacterial surveillance tool 
epithelial cells employ in order to respond to bacterial presence and pathogen invasion.  
Endogenous stimuli is also provided to the epithelium by tumor necrosis factor alpha (TNFα) that 
is produced by local immune and epithelial cells and is able to signal to epithelial cells through 
TNF receptor 1 (TNFR1) on the epithelial surface (218).  Various cell models have shown that 
high molecular weight adiponectin (HMWAd) has the capacity to modulate intracellular signaling 
through the NF-κB pathway (120, 127, 128) which is also utilized by all plasma membrane-
bound TLRs (130) as well as TNFR1 (218).  However, studies are lacking which investigate the 
combined effects on epithelial cells of these exogenous and endogenous stimulants in the 
presence of HMW adiponectin.  Here, we test the hypothesis that physiological concentrations 
HMWAd will dampen the capacity of bacterial products and TNFα to activate the NF-κB 
signaling cascade in oral and intestinal epithelial cells and subsequently modulate gene 
expression and cytokine secretion.    In addition, we show that AdipoR1 is expressed at higher 
levels than AdipoR2 at multiple sites along the gastrointestinal epithelium and that expression of 
AdipoR2, but not AdipoR1, is reduced in inflamed colonic tissue from patients with 
inflammatory bowel diseases. 
 
RESULTS 
 Expression of adiponectin receptors along gastrointestinal epithelium.  With the 
discoveries of adiponectin outside of systemic circulation in the oral and intestinal cavities, we 
investigated whether the adiponectin receptors were expressed on the epithelium of these sites 
along the gastrointestinal tract.  We found substantial ADIPOR1 and 2 expression in oral, ileal, 
and colonic epithelial biopsies from healthy volunteers (Fig. 3.1). The expression level of both 
receptors on the intestinal epithelium was relatively equivalent, but ADIPOR1 expression was 
significantly higher in the oral epithelium.           
HMWAd modulates cytokine secretion by epithelial cells.  Full-length adiponectin 
assembles into multiples of three during post-translational processing within the adipocyte (169).  
Multimers of 12-18 proteins connected have been classified as the high molecular weight form of 
the protein and are capable of affecting numerous cell types throughout the body.  Though 
AdipoR1 and AdipoR2 are found at very high expression levels on epithelial cells throughout the 
upper and lower gastrointestinal tract, little work has been done to elucidate what effects 
HMWAd has on these cells which mediate the barrier between the body proper and the outside 
environment.   
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The transformed OKF6 oral epithelial (194) and colonic adenocarcinoma HT-29 (200, 
219) cell lines are widely used as in vitro models to represent the main cell type of the oral and 
colonic epithelium, respectively.  OKF6 and HT-29 cells were treated with or without HMWAd 
for 18h and then stimulated with TNFα for 6h (Fig. 3.2).  Measurements of cytokine secretion in 
cell supernatants revealed that oral epithelial cells’ IFNγ, IL-12, IL-13, IL-8, TNFα, IL-10, IL-17, 
and IL-1β production was significantly raised after TNFα stimulation and IL-12, IL-8, IL-10, and 
IL-17 further increased after combined HMWAd and TNFα presence (Fig.3.2A).  Following 
HMWAd pretreatment, intestinal epithelial cells showed an increase in all cytokines measured, 
but only further increases of IFNγ over TNFα stimulation alone (Fig. 3.2B).   
OKF6 and HT-29 cells were also exposed to bacterial lipopolysaccharide (LPS, ligand 
for TLR4) or flagellin (ligand for TLR5) after HMWAd pretreatment (Fig.3).  In oral cells, 
significant increases in IFNγ, IL-12, IL-13, and IL-8 secretion was shown only after combined 
HMWAd pretreatment and flagellin stimulation and not with bacterial flagellin alone.  Consistent 
with previous studies in other cell types (122, 123), HMWAd by itself was able to induce IL-8 
expression and secretion in OKF6 cells.  Intestinal epithelial cells showed a different pattern of 
cytokine release with increases in production of all cytokines measured after stimulation with 
LPS or flagellin alone.  However, when cells were pretreated with HMWAd and then stimulated 
with flagellin, a significantly higher amount of IFNγ was produced while considerably less IL-12 
was made.  These findings suggest that HMWAd is important in regulating the epithelial cell 
response to endogenously-produced TNFα as well as perpetually present bacterial LPS and 
flagellin.     
Negative regulators of NF-κB signaling increased in response to HMWAd, TLR, 
and TNFR ligands.  Expression of AdipoR1 and AdipoR2 by various cell types has been shown 
to be slightly downregulated by cell exposure to TLR ligands (220) or cytokines (132).  
Consistent with previous findings, we saw a trend of slightly decreased AdipoR1 and AdipoR2 
expression when stimulated with TNFα (Fig. 3.4A) or TLR ligands (Fig. 3.5A).  However, 
expression levels of these two receptors were high on both OKF6 and HT-29 cells and were 
generally unaffected by provided stimuli. 
Signaling through all plasma membrane-bound TLRs utilizes the adaptor protein MyD88, 
which is able to activate gene expression through NF-κB activation and translocation to the 
nucleus (130).  In response to TLR 4 and 5 ligands and HMWAd, we measured changes in 
expression levels of the p65 (RelA) subunit of the NF-κB heterodimer, p65 reverse shuttling 
protein PPARγ, and IκBα deubquinating protein A20.  The p65 subunit is known to be a 
biomarker for intestinal homeostasis (221), while PPARγ (59) and A20 (222) work to directly 
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impede the NF-κB cascade.  OKF6 cells showed no significant changes in p65 or PPARγ 
expression in response to TNFα alone or combined with HMWAd, but gene expression of A20 
rose very sharply after a combined exposure to these two stimulants (a 350x-fold increase over 
unstimulated control) (Fig. 3.4B).  Significant increases in p65 and A20 expression were found in 
HT-29 cells stimulated with TNFα (Fig. 3.4B).  When pretreated with HMWAd before TNFα 
exposure, p65 and PPARγ both showed significant increases in expression over TNFα stimulation 
alone, while A20 showed an increase, but was below statistically significant levels.   
Consistent with TNFα stimulation, oral epithelial cells saw no changes in p65 or PPARγ 
expression, but immense upregulation of A20 expression in response to HMWAd (10x-fold 
increase) and even further increases with HMWAd pretreatment and LPS stimulation (Fig. 3.5B).  
Intestinal epithelial cells increased expression of p65 only after dual stimulation with HMWAd 
and a TLR ligand, suggesting synergy between the two unique signaling pathways.  The 
expression of A20 was upregulated in response to TLR ligands, but HMWAd had no additional 
effect on expression levels.  With dramatic increases in expression of negative regulators to NF-
κB signaling after combined HMWAd pretreatment with or without TNFα or TLR ligand 
stimulation, HMWAd appears to be involved in the process of dampening the NF-κB signaling 
cascade.                 
TNFα-induced NF- κB activity decreased in OKF6 cells after following HMWAd 
treatment.  Our gene expression data from both oral and intestinal epithelial cell types showed a 
possible role of HMWAd in the control of the NF-κB signaling cascade.  To test this possibility, 
we transfected OKF6 and HT-29 cells with an NF-κB reporter plasmid which expresses firefly 
luciferase when NF-κB-mediated transcription is initiated in the cell.  We then stimulated the 
epithelial cells in the similar fashion as previous experiments with an 18h HMWAd pretreatment 
and 6h stimulus with a TLR ligand or TNFα.  OKF6 cells did not alter NF-κB signaling when 
pretreated with HMWAd alone or stimulated with TLR ligands (Fig. 3.6A).  However, the oral 
cells did show a significant increase in NF-κB signaling when stimulated with TNFα, but this 
increase was brought down to basal levels when the cells were pretreated with HMWAd.  No 
change in NF-κB activity was seen when OKF6 cells were stimulated with LPS alone, but 
activity was significantly decreased below basal levels when cells were pretreated with HMWAd 
before LPS stimulation.  As shown in Fig 3.5A, combination of HMWAd and LPS was also 
responsible for significantly higher A20 expression when compared to HMWAd pretreatment 
alone.  This data is consistent with Figures 2 through 5 showing OKF6 cells’ hyporesponsiveness 
to TLR ligands alone and the profound ability of TNFα to stimulate oral cells.  HT-29 cells also 
showed a lack of increased NF-κB signaling in response to the TLR ligands LPS and flagellin, 
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but significantly higher signaling in response to TNFα.  Pretreatment with HMWAd did not affect 
the HT-29 cells’ ability to induce NF-κB mediated transcription for all stimuli provided.   
Translocation of p65 subunit of NF-κB to the cell’s nucleus is necessary to activate 
transcription through the canonical NF-κB signaling pathway (223).  To visualize this, we 
stimulated OKF6 and HT-29 cells for 2h with TNFα following pretreatment with or without 
HMWAd and then stained cells for intracellular localization of p65 (Fig. 3.6B).  In OKF6 cells, 
p65 was found almost exclusively in the nucleus after TNFα stimulation.  Pretreatment with 
HMWAd before TNFα stimulation showed the intracellular distribution of p65 to be much more 
similar to cells not treated with TNFα, indicating one possible mechanism employed by HMWAd 
to subdue NF-κB-mediated signaling.  HT-29 cells did not show a visible difference in p65 
translocation to the nucleus after TNFα stimulation.  OKF6 and HT-29 cells were also stimulated 
in a similar fashion for 1 and 4h with TNFα and showed no visible differences in p65 localization 
with respect to HMWAd pretreatment (Fig. 3.7).  Both cell types were also stimulated with LPS 
and flagellin in the same manner at various time points, but no differences were visible in the 
intracellular localization of p65 (data not shown).    
AdipoR1 and AdipoR2 expression in noninflamed and inflamed human gingival and 
colonic biopsies.  Inflammatory bowel diseases (IBDs) are characterized by uncontrolled 
pathological inflammation along the intestinal tract and the main subdivisions classified as 
Crohn’s Disease (CD) and Ulcerative Colitis (UC) (171).  Skip lesions of inflammation along the 
ileum and colon are characteristic of CD whereas UC generally presents as superficial ulceration 
along the distal colon.  Gene expression levels of AdipoR1 and AdipoR2 have been shown to be 
decreased in inflamed gingival tissue (131) and lower receptor expression is found to be 
associated with colorectal cancers (135) and worse prognosis with gastric cancer (133).    We 
investigated whether inflamed colonic tissue in CD and UC patients showed a difference in 
AdipoR1 and 2 expression when compared to non-inflamed colonic tissue within the same 
patient.  Paired biopsies were taken from patients with active flares that had been previously 
diagnosed with CD or UC: one from a region of inflammation in the colon and one from an area 
without inflammation.  Measurement of AdipoR1 and 2 gene expression from the paired biopsies 
showed no significant differences in AdipoR1 expression but a clear decrease in AdipoR2 
expression in inflamed biopsies for 82% (27 of 33) of paired biopsies (Fig. 3.8).  Interestingly, 
AdipoR2 has been identified as the receptor for the HMW multimer of the full-length adiponectin 
protein (214).  These data point to the possibility of loss of HMWAd recognition in the colon as a 
possible contributing factor in the exacerbation of inflammation in IBDs.   
 
45 
 
SUMMARY    
The results of this present study demonstrate the high-molecular weight form of the full-
length adiponectin multimer (HMWAd) acting through the NF-κB pathway in an “appropriate 
inflammatory” manner with both pro- and anti-inflammatory effects on oral and intestinal 
epithelial cells.  Through our observations, HMWAd itself had little impact on epithelial cell 
stimulation, but when combined with the bacterial products LPS and flagellin or the cytokine 
TNFα, epithelial cells showed increased secretion of pro-inflammatory cytokines as well as 
increased expression of negative regulators of the NF-κB signaling cascade.   
TNFα is continuously produced in small amounts along the epithelium by local immune 
cells and epithelial cells in response to microbial and environmental cues.  Consistent with 
previous reports, our oral and intestinal epithelial cell lines were very sensitive to stimulation 
with TNFα (200, 224), showing increased secretion of all cytokines measured (Fig. 3.2).  When 
cells were first pretreated with HMWAd, further increased production of multiple cytokines such 
as IL-12, IL-8, IL-10, and IL-17 in OKF6 cells and IFNγ in HT-29 cells shows the potential 
capacity of HMWAd to facilitate a pro-inflammatory response.  However, pretreatment with 
HMWAd and subsequent TNFα stimulation also induced expression of multiple negative 
regulators of NF-κB signaling, namely, A20 in OKF6 cells and both PPARγ and A20 in HT-29 
cells (Fig. 3.4B).  Following HMWAd pretreatment, NF-κB-induced transcriptional activity and 
p65 nuclear translocation were both reduced in OKF6 cells when compared to TNFα stimulation 
alone, showing how the HMW multimer can also act to dampen the NF-κB cascade and prevent 
an excessive inflammatory response (Fig. 3.6).  These findings add another piece to the body of 
evidence that NF-κB signaling in the epithelium is necessary for both the promotion and control 
of the local inflammatory response (225, 226).                             
We found that OKF6 cells were generally unresponsive to LPS with only increased 
secretion of IL-8 at the experimental concentration used (Fig. 3.3).  However, we did notice an 
interesting finding in that combined LPS stimulation and HMWAd pretreatment was able to 
significantly increase A20 expression over HMWAd pretreatment alone (Fig. 3.5B).  This 
revealed further consequences as shown by decreased NF-κB activity below basal levels when 
OKF6 cells were exposed to both HMWAd and LPS (Fig. 3.6A).  In contrast with oral cells, HT-
29 cells responded robustly to LPS and flagellin with increased secretion of IFNγ, IL-12, IL-13 
IL-8, and TNFα (Fig. 3.3).  In a similar fashion to TNFα stimulation, HT-29 cells also increased 
PPARγ expression with HMWAd pretreatment and LPS stimulation (Fig. 3.5).  In addition, 
adiponectin has been shown to bind the LPS of γ-Proteobacteria (227), suggesting another novel 
mechanism in which adiponectin inhibits PRR signaling.  Multiple flagellated bacteria found on 
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the oral and intestinal epithelium continuously shed the flagellin subunit which is recognized by 
another PRR, TLR5.  Much like LPS, OKF6 cells were generally unresponsive to flagellin alone.  
However, unlike LPS, when HMWAd pretreatment was combined with flagellin stimulation, 
IFNγ, IL-12, and IL-13 were all increased in these cells (Fig. 3.3).  Though HT-29 cells were able 
to increase multiple cytokines with flagellin stimulation alone, a similar phenomenon was found 
with IFNγ production significantly higher and IL-12 production lower when combining HMWAd 
pretreatment and flagellin stimulation.   For the HT-29 cells, this further extended into gene 
expression of NF-κB regulators, with only HMWAd and flagellin able to increase p65 and 
PPARγ expression (Fig. 3.5).  The modulation of cytokine secretion and gene expression patterns 
not by HMWAd alone or bacterial product alone but only in unison leads to the notion of 
intersecting intracellular signaling pathways between AdipoR2 and the TLRs.            
We found that epithelial cells in the human mouth, ileum, and colon express both of the putative 
adiponectin receptors, AdipoR1 and AdipoR2 (Fig. 3.1).  Constant exogenous insults from the 
resident microbiota require these cells to act in an appropriate manner, or potentially reduce the 
fitness of the host through oral or intestinal inflammation.  With the discovery of adiponectin in 
the intestinal lumen (139, 140) and high expression of AdipoR1 and 2 on IECs (134-136), this 
conjuncture hints to adiponectin as providing stimuli to IECs to possibly help deal with the 
extreme microbial burden.  We found that in IBD patients, expression of AdipoR1 in the colon 
was not different between non-inflamed and inflamed areas.  However, the expression of 
AdipoR2, which is the high-affinity receptor for HMWAd, was consistently reduced in the 
inflamed areas of the colon for almost all IBD patients (27/33, 82%) (Fig. 3.8).  Data from other 
groups has shown mesenteric fat as actually producing more adiponectin in Crohn’s disease (228) 
and during experimental colitis in rats (229).   However, without recognition by the epithelium 
through AdipoR2, no modification of inflammatory signaling pathways within IECs would take 
place.  This data provides rational to further study HMWAd modulation of inflammatory 
signaling pathways within the gastrointestinal epithelium, and points to the possibility of loss of 
“appropriate inflammatory” HMWAd signaling in the pathogenesis of IBDs. 
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Figure 3.1. Expression of mRNA for adiponectin receptors in different regions of the 
gastrointestinal tract. Biopsies of oral gingiva (n = 12), ileal mucosa (n = 15), and colonic mucosa 
(n = 15) biopsies were collected from healthy volunteers. Levels of ADIPOR1 and ADIPOR2 
mRNA were analyzed by qRT-PCR and normalized to β2-microglobulin mRNA. Data are 
expressed as mean ± SEM, and significance of differences between ADIPOR1 and ADIPOR2 
expression are noted for each tissue; n.s. = not significant.  
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Figure 3.2. Effect of high molecular weight adiponectin (HMWAd) pretreatment on TNF-
stimulated cytokine secretion by cultured human oral and intestinal epithelial cells. A, OKF6 oral 
epithelial and B, HT-29 intestinal epithelial cell-lines were cultured for 18 h in the absence or 
presence of HMWAd (1 μg/ml), then cultured for an additional 6 h without further treatment 
(control) or with the addition of TNF (10 ng/ml).  Cell supernatants were collected at the end of 
the 24 h culture period, and cytokine levels were analyzed by ELISA. Data are expressed as mean 
± SEM (n = 3). Asterisks denote a significant effect of TNF treatment, and triangles denote a 
significant effect of HMWAd pretreatment (p < 0.05).  
 
49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Effect of high molecular weight adiponectin (HMWAd) pretreatment on Toll-like 
receptor (TLR) ligand-stimulated cytokine secretion by cultured human oral and intestinal 
epithelial cells. A, OKF6 and B, HT-29 cells were cultured for 18 h in the absence or presence of 
HMWAd (1 μg/ml), then cultured for an additional 6 h without further treatment (control) or with 
the addition of the TLR4 ligand LPS (100 ng/ml) or the TLR5 ligand flagellin (70 ng/ml).  Cell 
supernatants were collected at the end of the 24 h culture period, and cytokine levels were 
analyzed by ELISA. Data are expressed as mean ± SEM (n = 3). Asterisks denote a significant 
effect of LPS or flagellin treatment, and triangles denote a significant effect of HMWAd 
pretreatment (p < 0.05).  
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Figure 3.4. Effect of high molecular weight adiponectin (HMWAd) pretreatment and TNF 
stimulation on expression of A) adiponectin receptors and, B) downstream signaling components. 
OKF6 and HT-29 cells were cultured for 18 h in the absence or presence of HMWAd (1 μg/ml), 
then cultured for an additional 6 h without further treatment (control) or with the addition of TNF 
(10 ng/ml).  Levels of mRNA encoding ADIPOR1, ADIPOR2, the p65 subunit of nuclear factor 
(NF)-κB, peroxisome proliferator-activated receptor (PPAR)γ, and the ubiquitin modifying 
enzyme A20 were analyzed by qRT-PCR and normalized to β2-microglobulin. Data are expressed 
as mean ± SEM (n = 3). Asterisks denote a significant effect of TNF treatment, and triangles 
denote a significant effect of HMWAd pretreatment (p < 0.05).  
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Figure 3.5. Effect of high molecular weight adiponectin (HMWAd) pretreatment and TLR ligand 
stimulation on expression of A) adiponectin receptors and, B) downstream signaling components. 
OKF6 oral epithelial and HT-29 intestinal epithelial cell-lines were cultured for 18 h in the 
absence or presence of HMWAd (1 μg/ml), then cultured for an additional 6 h without further 
treatment (control) or with the addition of the LPS (100 ng/ml) or flagellin (70 ng/ml).  Levels of 
mRNA encoding ADIPOR1, ADIPOR2, p65, PPARγ and A20 were analyzed by qRT-PCR and 
normalized to β2-microglobulin. Data are expressed as mean ± SEM (n = 3). Asterisks denote a 
significant effect of TLR ligand treatment, and triangles denote a significant effect of HMWAd 
pretreatment (p < 0.05).  
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Figure 3.6. Modulation of NF-κB activation by HMWAd. A, NF-κB reporter assay. OKF6 and 
HT-29 cells were transiently transfected with a reporter plasmid, in which expression of firefly 
luciferase is regulated by NF-κB-binding elements, and a control Renilla luciferase plasmid. 
Transfected cells were cultured for 18 h in the absence or presence of HMWAd (1 μg/ml), then 
cultured for an additional 6 h without further treatment (control) or with the addition of LPS (100 
ng/ml), TNF (10 ng/ml) or flagellin (70 ng/ml). NF-κB activity was calculated as the ratio of 
firefly to Renilla luciferase, and expressed as fold increase compared to the mean of untreated 
cells (mean ± SEM, n = 4 for OKF6 cells and n = 7 for HT-29 cells. Asterisks denote a significant 
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effect of TLR ligand treatment, and triangles denote a significant effect of HMWAd pretreatment 
(p < 0.05). B, Intracellular localization of the p65 subunit of NF-κB. OKF6 HT-29 were cultured 
for 18 h in the absence or presence of HMWAd (1 μg/ml), then cultured for an additional 2 h 
without further treatment (control) or with the addition TNF (10 ng/ml). Cytoplasmic and nuclear 
p65 were detected by immunofluorescence (p65 = green, DAPI-stained nuclei = blue). 
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Figure 3.7. Intracellular localization of the p65 subunit of NF-κB. OKF6 and HT-29 cells were 
cultured for 18 h in the absence or presence of HMWAd (1 μg/ml), then cultured for an additional 
1 or 4h without further treatment (control) or with the addition TNF (10 ng/ml). Cytoplasmic and 
nuclear p65 were detected by immunofluorescence (p65 = green, DAPI-stained nuclei = blue). 
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Figure 3.8. Expression of adiponectin receptors in paired biopsies of non-inflamed and inflamed 
colonic mucosa of patients with Crohn’s disease (CD) or ulcerative colitis (UC). Levels of 
mRNA for A, ADIPOR1 and B, ADIPOR2 were analyzed by qRT-PCR and normalized to β2-
microglobulin mRNA. Symbols represent individual patients, with lines connecting the values for 
non-inflamed and inflamed colonic mucosa for each patient.  Statistical significance of 
differences in mRNA levels between paired biopsies was determined by non-parametric paired 
sign test.                    
Copyright © Eric William Rogier 2012 
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Chapter 4  
 
STIMULATION OF COLONIC EPITHELIAL CELL GENE EXPRESSION BY SPECIFIC 
COMMENSAL BACTERIA AND LOCALIZATION OF SECRETORY IgA AND 
SECRETORY COMPONENT IN THE COLONIC MUCUS LAYER 
  
INTRODUCTION  
The intestine must constantly contend with a huge microbial burden which increases from 
around ten million in the ileum to over a trillion in the large intestine (9). Secretory IgA (SIgA) 
antibodies play a critical role in shaping the composition of this gut microbiota and in 
maintenance of intestinal homeostasis (230-232). The polymeric immunoglobulin receptor (pIgR) 
transports polymeric IgA antibodies from the basolateral to the apical surface of intestinal 
epithelial cells (also, IECs)(233), where proteolytic cleavage of the extracellular domain of pIgR 
(also known as secretory component, SC) releases SIgA into the intestinal mucus layer (99, 233).  
SC, either free or complexed to SIgA, participates in a variety of innate defense mechanisms, 
including prevention of bacterial adherence to the intestinal mucous layer and neutralization of 
potential pro-inflammatory factors (29, 112). The significance of pIgR in intestinal homeostasis is 
highlighted by observations that Pigr-/- mice are more susceptible than are wild-type mice to 
infection with Salmonella typhimurium (234) and to development of chemically-induced colitis 
(235). 
Colonic bacteria promote intestinal homeostasis by enhancing the physical integrity of 
the epithelium and preventing bacteria from translocating into the lamina propria and draining 
lymphoid tissues (9, 236). A recent analysis of combined data from 3 independent metagenomic 
studies indicated that the majority of colonic bacteria in healthy individuals belonged to one of 4 
phyla: Firmicutes (about 65% of total species); Bacteroidetes (about 23%); Proteobacteria (about 
8%); and Actinobacteria (about 3%) (237). Alterations in the composition of the colonic 
microbiota, characterized by relative increases in Proteobacteria and Actinobacteria and relative 
decreases in Firmicutes and Bacteroidetes, have been associated with increased risk for 
inflammatory bowel disease (IBD) (41). Probiotic strains of colonic bacteria have shown promise 
in the prevention and treatment of IBD, but further clinical and fundamental studies are needed to 
delineate the mechanisms by which different probiotics exert their beneficial effects (238-240). 
Cross-talk between commensal bacteria and IEC is mediated by several families of 
pattern recognition receptors (PRRs), including the Toll-like (TLR) and NOD-like receptor 
families (51, 241, 242). In previous studies, we demonstrated that signaling through TLR3 and 
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TLR4 up-regulates pIgR expression in the human IEC line HT-29 (243).  It is not known whether 
changes in the composition of the colonic microbiota affect pIgR expression in IEC, since the 
effect of different species of colonic bacteria on pIgR regulation has not been compared 
systematically. This present work assesses whether bacterial species representing the four major 
phyla of the colonic microbiota differentially regulate the expression of pIgR and other epithelial 
genes involved in intestinal immunity.  We found that pIgR expression in IECs along the colonic 
crypt was more towards the apical side of the crypt as the bacterial-dense distal colon is reached. 
In vitro studies showed that pIgR expression was selectively up-regulated in HT-29 cells in 
response to bacteria of the family Enterobacteriaceae of the phylum Proteobacteria, including 
the probiotic E. coli strain Nissle 1917 (EcN).  In a similar fashion, another intestinal epithelial 
cells line (CaCo-2 cells) also showed selective increases in both pIgR and Il-8 gene expression 
with only EcN able to upregulate both of these genes.  Both live and dead and EcN and 
Salmonella typhimurium bacteria were able to increase gene expression of pIgR and the pro-
inflammatory chemokine IL-8, indicating bacterial products are the driving force behind 
modulation of IEC gene expression.  Since epithelial cells arrange in a polarized fashion in vivo, 
we also investigated the stimulatory capacity of EcN to signal by both apical and basolateral 
membranes in HT-29 cells.  Our findings suggest that bacteria of the family Enterobacteriaceae 
regulate transport of SIgA antibodies into intestinal secretions by inducing pIgR expression in 
IECs by equal stimulation from both surfaces of the cell.  Furthermore, other bacterial species 
may play a role in the maintenance of barrier integrity in the colon. 
Once SIgA is cleaved from the epithelial surface, its release into the colonic mucus layer 
allows direct binding of the complex to bacteria residing in the host intestinal lumen.  Multiple in 
vitro studies have shown SIgA in the promotion of biofilm formation of intestinal mutualists (77, 
78, 110), but this concept does not have much in vivo backing.  The colonic lumen is separated 
from the epithelium by the colonic mucus layer, which is organized into two distinct layers, a 
dense inner layer directly above the epithelium and a loose outer layer overlaying the inner (35).  
The mucin protein, muc2, is the gel-forming mucin secreted from host goblet cells that allows 
formation of the intestinal mucus layers.  Proteomic analysis of these two layers have shown high 
levels of the IgG-binding Fc gamma binding protein (Fcγbp), but no putative host-derived 
proteins with IgA-binding capacity (36, 244).  The current assumption is that IgA binds glycan 
residues on the muc2 protein and primarily resides in the inner mucus layer (110, 149, 245) and 
aids the host by immune exclusion of bacterial antigens from the epithelial surface. 
Absence of the intestinal mucus layer is very detrimental to the host, and is a hallmark of 
multiple enteric diseases, including: bacterial infection (91, 246), parasitic infection (247), and 
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IBDs (248).  Usually found only in the outer mucus layer, bacteria and fecal material are in direct 
contact with IECs without a mucus barrier, and mice lacking the muc2 protein develop 
spontaneous colitis (88, 89).  Imaging of the mucus layer has historically been troublesome due to 
the high amount of water that is lost by tissue fixation with the conventional aldehyde- or 
hydrocarbon-based fixatives.  With the discovery of intestinal mucus preservation by the use of 
Carnoy’s fixative (35), a wealth of information regarding in situ mucus contents and bacterial 
interactions has been unearthed.  This study utilizes mucus-fixing techniques to show intermucal 
localization of the SIgA and SC proteins.  We found that, in mice, both of these proteins are 
concentrated in the outer mucus layer in the direct vicinity as the intestinal bacteria.  Outer mucus 
layer-localization of SIgA was also confirmed in the human colon.  These findings suggest one of 
the most important roles of SIgA and SC is immune exclusion in the outer, not inner, mucus layer 
and that these proteins and concentrate in areas of highest microbial product density.                     
 
RESULTS 
Apical localization of pIgR-producing IECs along length of colon is directly 
correlated with concentration of bacteria.   The colon is made of repeating subunits of the 
crypts of Lieberkühn (or, crypts) (Fig. 4.1A).  Directly beneath and between the crypts lie the 
lamina propria containing immune cells.  The innervated and vascularized muscularis mucosae is 
directly beneath the laminia propria, and the foundational submucosa provides structural support 
to the colon.  In the colon, SIgA directly works to bind bacteria in the lumen and prevent 
migration into the colonic epithelium.  Efflux of IgA across colonic epithelial cells requires the 
pIgR protein, so we investigated the crypt-specific localization of pIgR at different sites along the 
colon.  To our surprise, seemingly specific sets of colonic epithelial cells produced pIgR 
depending upon which location of the colon was surveyed (Fig. 4.1B).  Apical crypt localization 
became more prominent as the distal colon was approached with most of the pIgR-positive cells 
in the rectum being on the apical tip of colonic crypts.  The pIgR produced in the lower portion of 
the crypt is likely cleaved with IgA and carried to the intestinal lumen by the mucal current, but 
pIgR produced at the apical tips of the crypts is probably cleaved and directly released with IgA 
into the inner mucus layer.  This differential expression pattern could have an effect on the way 
SC and SIgA interacts with the microbiota in the intestinal lumen. Interestingly, pIgR localization 
became more apical in parallel with increasing bacterial concentration in the colon, possibly as an 
effect of higher MAMP-induced expression of pIgR in the distal colon.            
Regulation of gene expression in human intestinal epithelial cells by commensal 
bacteria representing the four major phyla of the colonic microbiota. We and others have 
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demonstrated that pIgR expression is regulated in HT-29 cells by cytokines known to modulate 
intestinal immunity in humans, including IFN-γ, TNF, IL-1 and IL-4 (192, 200, 249-262).  The 
HT-29 cell-line has subsequently been used as a model system to identify basal and cytokine-
inducible regulatory elements in the human PIGR gene (262-270). A potential role for commensal 
bacteria in pIgR regulation was first suggested by the finding that butyrate, a by-product of 
bacterial fermentation, up-regulated pIgR expression in HT-29 cells (271).  We subsequently 
demonstrated that bacterial LPS up-regulated pIgR expression in HT-29 cells, suggesting that 
bacterial-epithelial cross-talk via TLR signaling may regulate transport of secretory 
immunoglobulins (243).  To compare the ability of different species of colonic bacteria to 
regulate pIgR expression, we analyzed pIgR mRNA levels in HT-29 cells stimulated with heat-
killed bacteria of representative species from the four major bacterial phyla of the human colonic 
microbiota (Table 4.1)(Fig. 4.2A). Preliminary studies with selected species demonstrated that 
induction of pIgR expression in response to heat-killed or live bacteria were similar (data not 
shown). Table 4.1 describes the phylogeny of the bacteria used in this study, all of which were 
environmental strains originally isolated from human fecal material. Individual species were 
chosen based on their relevance to the pathogenesis or prevention of IBD in humans. A recent 
study reported that relative numbers of Clostridium nexile (also, Cn), 
Bacteroides thetaiotaomicron (also, Bt) and Alistipes onderdonkii (Ao) were reduced in the 
colonic microbiota of patients with IBD, whereas relative numbers of Pseudomonas straminea 
(Pstr) , Escherichia coli (Ec) and Pimelobacter simplex (Psim) were increased (41).  The 
probiotic species Lactobacillus acidophilus (La) and Bifidobacterium longum (Bl) were included 
in this experiment because of their widespread use in fermented milk products and other probiotic 
formulations (239, 272). Interestingly, EcN was unique among these 8 commensal species in its 
ability to induce expression of pIgR. Levels of pIgR mRNA increased slowly in response to EcN 
stimulation, with a small but significant increase at 3h and a much larger increase at 24h.  The 
delayed increase in pIgR expression in response to EcN is consistent with our previous 
observations with LPS and other TLR ligands (243). We and others have observed delayed 
responses of pIgR to cytokine stimulation, due to a requirement for de novo synthesis of one or 
more transcription factors (243, 254, 255, 263, 265-267, 273). The delayed response of pIgR to 
bacterial stimulation suggests that there may be a similar requirement for a newly synthesized 
transcription factor.  In our previous studies involving stimulation of HT-29 cells with cytokines 
and TLR ligands, we found that levels of membrane and secreted pIgR protein were directly 
correlated with levels of pIgR mRNA (243, 255). We found that EcN caused a rapid induction in 
mRNA for the pro-inflammatory factors IL-8 and TNF, which declined significantly by 24 h (Fig. 
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4.2B). The observed down-regulation of IL-8 and TNF could be attributed in part to the induction 
of A20, a ubiquitin-editing enzyme that down-regulates NF-κB signaling (55), and mitogen-
activated protein kinase phosphatase (MKP)-1, a negative regulator of MAP kinase signaling 
(274)(Fig. 4.2B).  We also tested an additional colonic epithelial cell line (CaCo-2 cells) to see if 
the stimulatory specificity of EcN was applicable to other CEC models.  Using a single 
representative from the four prominent intestinal phyla, we found only EcN was able to induce 
gene expression of Il-8 after 3h stimulation whereas both EcN and La significantly increased 
pIgR mRNA after 24h with higher levels seen after EcN treatment (Fig.4.3).  Though slightly 
different from HT-29 cells, the results of CaCo-2 stimulation showed the same trend of the 
Proteobacteria species EcN as having the most profound effect on CECs.         
As a control to assess the potential activity of bacteria that did not induce gene expression 
in HT-29 cells, the THP-1 human monocyte cell-line was stimulated with heat-killed bacteria of 
the same species (Fig. 4.2C). Levels of pIgR mRNA were negligible in THP-1 cells even after 
bacterial stimulation (data not shown), consistent with the epithelial-specific expression of pIgR 
(99). Every commensal species induced expression of IL-8 and TNF in THP-1 cells to levels 100-
fold higher than those seen in HT-29 cells. Only selected species, including EcN, induced 
expression of the negative regulators A20 and MKP-1 in THP-1 cells. These results suggest that 
the potential to induce a pro-inflammatory response in innate immune cells is widespread among 
commensal bacteria, but that IEC may respond only to a subset of bacteria. 
The epithelium is a polarized layer of epithelial cells with an apical side that faces the 
intestinal lumen and a basolateral side that faces the lamina propria.  Tight junctions between 
epithelial cells ensure minimal diffusion of luminal contents across the epithelial barrier, but 
bacterial products and other antigens do occasionally traverse this barrier, especially under 
periods of inflammation (185).  To investigate the consequences of EcN stimulation from both of 
these surfaces, we grew HT-29 cells to confluent single-cell monolayers on Transwell inserts, 
which contain a porous membrane to allow diffusion  of liquid to the basolateral surface of the 
cell monolayer.  Induction of pIgR expression was equally attainable by both apical and 
basolateral stimulation with heat-killed EcN after 3,6,12, and 24h (Fig. 4.4A).  Upregulation of Il-
8 was significantly higher at 6h when HT-29 cells were stimulated apically, but not different at 
3,12, and 24h timepoints (Fig. 4.4A).  Directional secretion of the Il-8 protein was also assayed in 
apical and basal supernatants (Fig. 4.4B).  With the exception of the 24h timepoint, HT-29 cells 
consistently secreted higher amounts of Il-8 from the apical side of the cells.  This chemotactic 
protein is well known for its ability to recruit neutrophils to the site of infection, so it is 
interesting that more Il-8 would be excreted towards the direction of the intestinal lumen as 
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opposed to the lamina propria.  However, since pathogenic bacteria may reside at the epithelial 
surface or in colonic crypts (275), perhaps the best place for the phagocytic/reactive oxygen-
producing immune cells is in the midst of the harmful microbes.             
Regulation of pIgR expression in HT-29 cells by commensal and pathogenic bacteria 
of the family Enterobacteriaceae.  We found that EcN, a commensal bacterium of the family 
Enterobacteriaceae (phylum Proteobacteria) was unique in its ability to induce gene expression 
in HT-29 cells (Fig. 4.2). The failure of other commensal species to induce gene expression could 
be due to a lack of recognition of those species by cellular PRRs or active inhibition of PRR 
signaling. If the latter mechanism was operative, the presence of “inhibitory” bacteria might 
down-regulate the response to EcN. To test this hypothesis, HT-29 cells were exposed to heat-
killed EcN in the presence or absence of equivalent doses of Lactobacillus acidophilus (La, 
phylum Firmicutes), Bacteroides thetaiotaomicron (Bt, phylum Bacteroidetes) or 
Bifidobacterium longum (Bl, phylum Actinobacteria) (Fig. 4.5). As expected, EcN stimulation 
resulted in early induction of IL-8 mRNA and delayed induction of pIgR mRNA. None of the 
bacteria from other phyla, alone or in combination with EcN, significantly affected expression of 
pIgR or IL-8. These findings suggest that concurrent exposure to other types of commensal 
bacteria does not significantly dampen the response of intestinal epithelial cells to EcN. However, 
the possibility remains that a complex mixture of commensal bacteria could modify the response 
to EcN or other bacteria of the family Enterobacteriaceae.  
To examine the ability of IECs to discriminate between closely related commensal and 
pathogenic species of the family Enterobacteriaceae, HT-29 cells were co-cultured with EcN or 
Salmonella typhimurium (St) strain SL1344. Following 1h of culture, relative numbers of EcN or 
St associated with the plasma membrane of HT-29 cells were found to be similar, whereas only St 
was capable of cellular invasion (Fig. 4.6A). This result is consistent with reports demonstrating 
higher invasiveness of St in HT-29 cells compared to several nonpathogenic E. coli strains, 
including EcN (276, 277). To compare the responses to living vs. dead bacteria, HT-29 cells were 
exposed to live or heat-killed EcN or St for 3h (Fig. 4.6B). Interestingly, early induction of IL-8 
expression was greater in response to live EcN than live St, whereas no differences were observed 
in the responses to heat-killed EcN vs. St. Expression of pIgR was not induced following 3h of 
stimulation with either live or dead bacteria. Comparison of the responses at 24h to EcN and St 
was complicated by the fact that the viability of HT-29 cells declined after exposure to live 
bacteria for more than 3h (data not shown). To determine whether changes in gene expression 
persisted after removal of bacterial stimuli, HT-29 cells were treated for 3 h with live or heat-
killed EcN or St, washed with antibiotic-containing culture medium, and cultured for an 
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additional 21h (24h harvest). Under these conditions, pIgR mRNA levels were not significantly 
different from those in untreated HT-29 cells, suggesting that continuous exposure to bacterial 
components is required to induce pIgR expression (compare Fig. 4.6B to Fig. 4.2A and 4.4A). 
The lack of significant IL-8 expression at 24 h was likely due to a combination of withdrawal of 
bacterial stimulation and induction of negative regulatory pathways. 
Stimulation of CEC monolayers with pathogenic or commensal bacteria reduces 
fluid diffusion across monolayer.  Signaling of bacterial products through TLRs and other PRRs 
is known to improve intestinal barrier function in vivo, and one of the most striking features of the 
germ-free mouse  is the ability of interstitial fluid to seep into the intestinal lumen (150).  To 
explore the capacity of pathogenic and commensal microbes to reduce CEC barrier leakiness, we 
grew HT-29 cells on Transwell inserts and apically exposed the cells to live pathogenic (St) or 
commensal (EcN or Bt) bacteria for 9h then measured monolayer permeability by FITC-dextran 
flux across the epithelial cell monolayer (Fig. 4.7).  As expected, the presence of the HT-29 
monolayer significantly reduced FITC-dextran flux across the Transwell membrane.  
Unexpectedly, all three live bacteria used were able to further reduce diffusion across the 
membrane, suggesting a common response by the intestine when pathogenic and commensal 
bacteria are in close contact with the epithelium.              
 Absence of colonic mucus changes colonic crypt morphology.  Mucin2 (muc2) is the 
primary secreted gel forming mucin protein in the colon intestine.  Constant synthesis, 
intracellular oligomerization, and secretion of this protein allows the formation of the colonic 
mucus layer (33).  We observed mouse goblet cell extrusion of mucus into the empty crypt space 
and unidirectional migration to the colonic lumen (Fig. 4.8A).   Goblet cells constitute 
approximately 15% of colonic epithelial cells, and their intracellular mucin granules hold the 
majority of the goblet cell volume (84).  We observed that mouse goblet cells unable to produce 
the muc2 protein lose a tremendous amount of volume in vivo and are indistinguishable from 
absorptive enterocytes (Fig. 4.8B).  The loss of this protein has other effects on the intestinal 
mucosa, and clear differences are seen with respect to crypt elongation, erosion of the epithelial 
surface, and detachment of IECs from the apical surface of the crypts.   
          Intestinal IgA and pIgR secretory component (SC) both concentrated in outer colonic 
mucus layer.  An immense amount of SIgA and SC are secreted by the intestinal epithelium 
daily (105), and can be found in both mucosal scrapings and stool samples.  The mouse deficient 
for the pIgR protein is unable to actively transport IgA into the intestinal lumen, and is unable to 
produce SIgA or SC (75), while the muc2-deficient mouse cannot form an intestinal mucus layer 
(Fig. 4.8B).  To investigate the in situ localization of SIgA, we stained Carnoy’s-fixed colons 
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from wild-type, Pigr -/-, Muc2 -/-, and Pigr -/-Muc2 -/- mice with antibodies against the muc2 and 
IgA proteins (Fig. 4.9).  In all four genotypes of mice green IgA-positive plasma cells can be seen 
throughout this intestinal mucosa.  Wild-type mice show a clear mucus layer with inner and outer 
layers, and strong colocalization of muc2 and IgA in the outer mucus layer.  While both mucus 
layers can still be seen in the Pigr -/- mice, very little dual staining exists in the outer mucus layer.  
The Muc2 -/- mice are still able to transport IgA into the intestinal lumen, but in the absence of a 
mucus layer, the antibody is simply integrated into the luminal contents and has no structured 
distribution.  The colonic epithelial interface of Pigr -/-Muc2 -/- mice lacks both a mucus layer and 
IgA transport into the lumen.  The same phenomenon of IgA localization was seen at the human 
colonic interface (Fig. 4.13).  The human colonic mucosa contains a much higher amount of IgA-
secreting plasma cells than the mouse mucosa, likely due to the non-sterile environment human 
immune systems contend with.  As with the mouse colons, we observed goblet cells actively 
secreting mucus into the colonic lumen, but much higher human colonic IgA concentrations 
allowed visualization of threads of IgA being pushed from the epithelial surface towards the outer 
mucus layer where IgA was actively accumulating.  These observations in mice and humans 
points towards a common mechanism of IgA migration to the outer mucus layer in the colon.         
 In the same manner as IgA, we also noticed SC accumulation in the outer mucus layer 
(Fig. 4.10).  As with IgA, the inner mucus layer provided a clear boundary between the colonic 
epithelium (dotted white line) and the accumulation of SC in the colonic lumen.  Moreover, this 
boundary is eliminated when mice are unable to produce a mucus layer, and Muc2 -/- mice show 
SC in the colonic lumen, but in a disorganized manner. 
 Bacteria require mucus layers, but not SIgA to remain separated from colonic 
epithelium.  Multiple reports have shown the utility of the intestinal mucus layer in the 
separation of the microbiota from the epithelial surface by isolation of bacteria into the outer 
mucus layer (36, 91).  To investigate whether IgA was also necessary for bacterial segregation, 
we used fluorescence in situ hybridization (FISH) to visualize bacterial localization in our four 
genotypes of mice (Fig. 4.11).  With both wild-type and Pigr -/- mice, we observed a clear 
separation between the microbiota and the surface of the epithelium.  However, when the mucus 
layer is absent, bacteria are in direct contact with the epithelium, regardless if IgA is in the 
intestinal lumen or not.  These data show that the colonic mucus layer, but not IgA actively 
partakes in the separation between host and bacteria.   
 Bacterial migration into the colonic crypts is a hallmark of severe inflammatory disease 
in both mice (91, 275) and humans (278).  We observed deep crypt invasion of intestinal bacteria 
in both Muc2 -/-, and Pigr -/-Muc2 -/- mice, but never in wild-type or Pigr -/- animals (Figure 4.12).  
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It is important to note that the colons of Muc2 -/-, and Pigr -/-Muc2 -/-  mice showed no signs of 
overt inflammation and never presented with blood in luminal contents.  This finding further 
shows the important nature of the colonic mucus layer, but not IgA, in keeping a barrier in 
between the intestinal microbiota and the host epithelium.       
 
SUMMARY 
 At the mucosal surface, SIgA antibodies carry out the multiple functions including 
neutralizing potentially invasive pathogens and shaping the composition of the commensal 
microbiota (230-232).  Here, we show potential mechanisms for microbiota promotion of SIgA 
transport to the colonic mucus layer as well as SIgA and SC localization once deposited in the 
mucus.  We also show that mucus, but not SIgA is necessary for the separation of host and 
bacteria in the colon.  The pIgR protein was found to be expressed in different sets of colonic 
epithelial cells depending on what site was surveyed along the colon (Fig. 4.1B). Interestingly, 
crypt apical expression of pIgR is directly correlated to the putative bacterial burden in the 
colonic lumen. In stimulating in vitro colonic epithelial cells, we found EcN to be unique among 
representative species from the 4 major phyla of human colonic bacteria in its ability to up-
regulate expression of pIgR in the human IEC line HT-29 (Fig. 4.2A).  In addition, EcN was also 
the only commensal to increase gene expression of the immune proteins Il-8 and TNF as well as 
the negative regulator of NF-κB signaling, A20.  This finding was repeated in CaCo-2 cells with 
only EcN able to increase both pIgR and Il-8 expression in the cells (Fig. 4.3).  We found that 
HT-29 cells responded to whole EcN, although not as robustly as the THP-1 monocyte cell-line 
(Fig. 4.2). Interestingly, HT-29 cells did not respond to other Gram-negative bacteria, including 
Pseudomonas straminea, which like EcN is a member of the phylum Proteobacteria, and two 
members of the phylum Bacteroidetes, Bacteroides thetaiotaomicron and Alistipes onderdonkii. 
Analyses of the structural requirements for TLR4-mediated signaling have suggested that the 
ability to act as a ligand for TLR4 is restricted to LPS molecules from a limited group of Gram-
negative bacteria, in particular those of the family Enterobacteriaceae (47, 279).  Both the apical 
and basolateral and surfaces of HT-29 cells were equally responsive to stimulation with EcN (Fig. 
4.4A), but Il-8 secretion from the apical side of these monolayers was consistently higher than 
from the basal side (Fig. 4.3B).  Physiologically, this may point to a method used by the intestinal 
epithelium in order to recruit neutrophils to the location of the bacterial threat.  We unexpectedly 
found both pathogenic and commensal bacteria as having the ability to decrease epithelial 
monolayer permeability (Fig. 4.7), pointing to a common response of the epithelium to any 
intimate bacterial-IEC contact.  Following release from the epithelium, both SC and SIgA were 
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found to be concentrated in the outer mucus layer, which was completely ablated in the absence 
of the muc2 protein (Figs. 4.9,4.10).  This occurrence was not specific to mice, as the human 
colonic epithelium showed the same pattern of IgA localization in the outer mucus layer (Fig. 
4.13).  The outer mucus layer is also the residence for the colonic microbiota (36), as shown by 
FISH staining for bacteria and immunofluorescence detection of IgA (Fig. 4.11).  Presence of the 
muc2 protein is necessary for separation of bacteria from the epithelial surface, but the absence of 
SIgA does not affect the bacterial localization.  Without an established mucus layer, bacteria are 
able to invade the colonic crypt space, which is also independent of presence or absence of pIgR 
(Fig. 12).  Our data point towards a model of ‘selective ignorance’ with of IEC recognition of 
only certain commensals.  Furthermore, SIgA may encourage immune exclusion of the 
microbiota by promotion of biofilm development and, ultimately, segregation of bacteria to the 
outer mucus layer.        
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Table 4.1: Bacteria used for the stimulation of cell lines   
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Figure 4.1.  Architecture of colonic crypts and localization of pIgR along mouse colon.  The 
colon is composed of repeating units denoted as crypts.  A) H&E stain of two tandem crypts in 
colon showing primary features as well as rotund mucus-secreting goblet cells and columnar 
absorptive enterocytes along length of crypt.  B) Immunostaining for pIgR (FITC, green) and 
counterstaining for DNA (DAPI, blue) showing increased pIgR protein at crypt apical surface as 
the distal colon is approached.  Scale bar = 50µm.       
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Figure 4.2. Regulation of gene expression by commensal bacteria representing the four major 
phyla of the human colonic microbiota. See Table 4.1 for a description of bacterial phylogeny. 
Abbreviations: La, L. acidophilus; Cn, C. nexile; Bt, B. thetaiotaomicron; Ao, A. onderdonkii; 
Pstr, P. straminea; EcN, E. coli Nissle; Bl, B. longum; Psim, P. simplex. A) HT-29 cells were 
cultured for 3 or 24h with heat-killed bacteria at a ratio of 10-20 bacterial cells per eukaryotic 
cell. pIgR mRNA levels were quantified by qRT-PCR and normalized to GAPDH mRNA. Data 
from 3 independent experiments were combined and expressed as mean ± SEM (n = 8). Asterisks 
indicate that the mean is significantly different from the mean for untreated HT-29 cells at 3 h 
(p < 0.05). B,C) Analysis of mRNA for pro-inflammatory factors and negative regulators in HT-
29 and THP-1 cells treated as described for panel A. Data from 3 independent experiments were 
combined and expressed as mean ± SEM (HT-29, n = 8; THP-1, n = 9). Asterisks indicate that the 
mean is significantly different from the mean for untreated cells from the same cell-line at 3h 
(p < 0.05). 
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Figure 4.3.  Human Caco-2 colonic adenocarcinoma cells display similar gene expression pattern 
as HT-29 cells when stimulated with commensal bacteria.  Caco-2 cells were grown to 70% 
confluency and stimulated with indicated bacterium representing one of the three dominant 
bacterial phyla in the human intestine (abbreviations and taxonomy displayed in Table 1).  As 
with HT-29 cells, EcN gave most dramatic increases in gene expression of pIgR and IL-8, but La 
was also able to significantly increase pIgR expression following 24h stimulation.  Data 
representative of one experiment with error bars displayed as SEM (n=3). * -gene expression 
significantly (p<0.05) different in eukaryotic cells stimulated with bacterium versus unstimulated 
cells. 
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Figure 4.4.  Modulation of pIgR and IL-8 gene expression and secretion of IL-8 after apical and 
basal stimulation of HT-29 cells with EcN.  HT-29 cells were allowed to grow to confluent 
monolayer on Transwell inserts and then stimulated with 107CFU/mL EcN for 3,6,12,or 24 hours 
on the apical or basal side of the cells.  Gene expression of pIgR and IL-8 is expressed in fold 
increase over unstimulated HT-29 cells.  Stimulation of either apical or basal side of epithelial 
cells with EcN shows an equal capacity to induce gene expression (A).  Supernatants were 
collected at various time points from either apical or basal side of cell monolayer to determine IL-
8 secretion through ELISA.  IL-8 protein shows preferential secretion from apical surface after 
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stimulation with EcN (B). Only the 24h time point of EcN stimulation causes that specified time 
point to have significant differences in apical vs. basal stimulation, however,  apical stimulation 
showed significantly higher IL-8 secretion for the cumulative experiment of all time points when 
compared to basal stimulation.  Data are averages±SEM of two independent experiments with 
n≥5 for gene expression and n=6 for ELISA data.  * -gene expression or IL-8 secretion 
significantly (p<0.05) different in apical vs. basal stimulation at indicated time point.  †- IL-8 
secretion significantly (p<0.05) higher in apical supernatants compared to basal supernatants at 
indicated time point. 
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Figure 4.5. Effect of addition of bacteria from different phyla on the response of HT-29 cells to 
E. coli Nissle. HT-29 cells were cultured for 3 or 24 h with heat-killed E. coli Nissle, L. 
acidophilus (La), B. thetaiotaomicron (Bt), or B. longum (Bl), as indicated. Each bacterial species 
was added at a ratio of 10-20 bacterial cells per eukaryotic cell. mRNA levels were quantified by 
qRT-PCR and normalized to GAPDH mRNA. Data from 2 independent experiments were 
combined and expressed as mean ± SEM (n = 7). Statistical comparisons of the overall effects of 
time and bacterial stimulation on pIgR and IL-8 mRNA are noted in the analysis of variance 
table. 
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Figure 4.6. Induction of gene expression in HT-29 cells by live or heat-killed bacteria of the 
family Enterobacteriaceae. A) Bacterial invasion assay. Six replicate cultures of HT-29 cells 
(approximately 106 cells/culture) were incubated for 1h with the indicated concentration of E. coli 
Nissle or S. typhimurium. After removal of culture supernatants to obtain final bacterial 
concentrations, triplicate cultures of HT-29 cells were analyzed for either membrane-associated 
or internalized bacteria as described in Materials and Methods. Statistical comparison: a, numbers 
of membrane-associated S. typhimurium were significantly greater than numbers of membrane-
associated E. coli Nissle (p < 0.05). B) HT-29 cells were cultured for 3h with live or heat-killed 
bacteria of the commensal E. coli Nissle (EcN) or the pathogen Salmonella typhimurium (St) at a 
ratio of 10 bacterial cells per eukaryotic cell. HT-29 cells were either harvested immediately (3h 
harvest), or washed and cultured in antibiotic-containing medium for an additional 21h (24h 
harvest). mRNA levels were quantified by qRT-PCR and normalized to GAPDH mRNA. Data 
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from 3 independent experiments were combined and expressed as mean ± SEM (n = 10). 
Statistical comparisons: a, mean is significantly different from the corresponding mean for 
untreated HT-29 cells (p < 0.05); b, mean for HT-29 cells treated with St is significantly different 
from the corresponding mean for cells treated with EcN (p < 0.05); c, mean for HT-29 cells 
treated with heat-killed bacteria is significantly different from the corresponding mean for cells 
treated with live bacteria (p < 0.05). 
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Figure 4.7. Both commensal and pathogenic bacteria decrease epithelial monolayer permeability.  
Epithelial cells allowed to grow to confluent monolayers on Transwell inserts and then exposed to 
102 live bacteria for 9 hours.  Monolayer permeability measured by adding 5mg/mL 3kD FITC-
dextran to Transwell apical chamber and collecting well basal chamber volume after 3h and 
reading flow-through FITC concentration by spectrophotometer.  Flux across HT-29 monolayer 
measured by: [µg FITC-dextran in basal chamber / time (in seconds)].  FITC-dextran ability to 
cross Transwell membrane significantly reduced by monolayer of epithelial cells and further 
reduced by pathogenic or commensal bacteria.  Data are averages±SEM from 2 independent 
experiments with n=3.    **, p<0.0001, *,  p<0.01 
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Figure 4.8.  Change in colonic crypt morphology and absence of mucus layer in mice lacking 
Muc2 protein production.  A) H&E stain of wild-type mouse colon showing crypt architecture 
and mucus production and excretion from goblet cells.  Panel to right is magnified section of 
black box.  B) H&E stain of Muc2 -/- mouse colon showing elongated crypts, goblet cell atrophy, 
and erosion of the epithelium with epithelial cell detachment.  Panel to right is magnified section 
of black box.  Bar = 50μm for all panels. 
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Figure 4.9. IgA localizes to outer mucus layer in colon.  Immunofluorescence histochemistry of 
wild-type, Pigr -/-, Muc2 -/-, and Pigr -/-Muc2 -/- mouse colons staining for IgA (FITC, green), 
Muc2 (Rhodamine, red), and counterstained for nuclei (DAPI, blue).  In Muc2 +/+ mice, a clear 
boundry exists between the inner and outer mucus layer with high concentrations of IgA in outer 
layer of Pigr sufficient mice as indicated by bright yellow combination of signals.  Pigr +/+ mice 
unable to retain IgA above colonic epithelium in absence of mucus layer.  Bar =50μm. 
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Figure 4.10.  Cleavage product of Pigr, secretory component (SC), also localizes to outer mucus 
layer in colon.  Immunofluorescence histochemistry of wild-type, Pigr -/-, Muc2 -/-, and Pigr -/-
Muc2 -/- mouse colons staining for Pigr/SC (FITC, green) and counterstained for nuclei (DAPI, 
blue).  White dotted line indicates boundary between epithelial surface and lumen.  Whole pIgR 
protein can be seen in lower and middle crypts in the colon.  Bar = 50μm. 
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Figure 4.11.  Intestinal bacteria are found in the outer mucus layer with IgA, but are in direct 
contact with colonic epithelium in absence of mucus layer.  Also, pIgR/SC not required to keep 
bacteria in outer mucus layer.  Wild-type, Pigr -/-, Muc2 -/-, and Pigr -/-Muc2 -/- mouse colons 
visualized by fluorescence in situ hybrizidation (FISH) labeling of intestinal bacteria (Cy5-Eub 
probe, magenta), immunostaining for IgA (FITC, green), and counterstaining for nuclei (DAPI, 
blue). 
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Figure 4.12.  Absence of mucus layer, but not pIgR and SIgA allows deep invasion of intestinal 
bacteria into colonic crypts.  Colons of Pigr -/-, Muc2 -/-, and Pigr -/-Muc2 -/-  mice labeled with 
FISH probe against intestinal bacteria (Cy5-Eub probe, magenta) and counterstained for nuclei 
(DAPI, blue).  Bar = 50μm.  
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Figure 4.13.  Human colon shows similar pattern of IgA migration to outer mucus layer and 
accumalation. A section of human colon actively secreting IgA and mucus stained for IgA (FITC, 
green), Muc2 (Rhodamine, red), and counterstained for nuclei (DAPI, blue).  Bar = 50μm.     
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Chapter 5 
 
NEONATES NOT RECEIVING MATERNAL SECRETORY IMMUNOGLOBULIN A SHOW 
PROFOUND SHIFTS IN INTESTINAL MICROBIOTA AND EPITHELIAL GENE 
EXPRESSION AS ADULTS 
 
INTRODUCTION  
 Immediately following birth, infant immune systems must contend with the world of 
microbes that will be with them for their entire lives.  Failure of the neonatal immune system to 
appropriately respond to these bacterial immigrants onto and in their bodies can lead to severe 
systemic and enteric infections, one of the most deadly being necrotizing enterocolitis (NEC) 
with a mortality rate upwards of 30% (280).  Infant immunity is initially deficient due to lack of 
activating surface proteins on immune cells (281), but the child’s gastrointestinal (GI) tract is 
bolstered by supplementation with maternal milk.  Besides the standard nutritional components, 
human milk provides many bioactive factors to the infant, including antimicrobial proteins, 
prebiotics, anti-inflammatory agents, cytokines, and immunoglobulins (282).  By far, the most 
abundant immunoglobulin in human milk is secretory IgA (SIgA), which is the product of 
proteolytic cleavage from the polymeric immunoglobulin receptor (pIgR) transporter at the 
mammary lobe epithelium.  To investigate the consequences of neonates not receiving SIgA 
during suckling, we compared mouse neonates from pIgR-deficient dams to pIgR-sufficient 
dams.  Using a systematic breeding scheme, we generated offspring from both maternal 
genotypes which were, themselves, pIgR-deficient or pIgR-sufficient.  This allowed us to 
compare offspring phenotype as a result of maternally-supplied (passive SIgA) or endogenously-
produced (active SIgA) antibodies.  We found that mice not receiving passive SIgA had high 
amounts of the opportunistic bacteria Ochrobactrum anthropi in their mesenteric lymph nodes 
(MLNs), as well as intestinal microbiotas which were distinctive at weaning and adulthood from 
offspring receiving passive SIgA during suckling.  In addition, passive SIgA played a much more 
prominent role compared to active SIgA in modulation of adult colonic epithelial cell (also, CEC) 
gene expression with and without chemically-induced colitis.  Overall, this work supplies 
experimental evidence to the role of maternally-supplied SIgA in the protection against bacterial 
invasion, establishment of the intestinal microbiota, and influence on CEC gene expression long 
after the nursing period.   
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RESULTS 
 SIgA, but not IgA, travels from lactating dam to neonate colon.  Our animal breeding 
scheme (Fig. 5.1A) allowed generation of pIgR sufficient and deficient offspring from both pIgR 
sufficient and deficient dams.  This allowed us to compare the effects on offspring phenotype of 
passively-supplied versus actively-supplied SIgA.  As expected, dams deficient for the pIgR 
protein were unable to produce SIgA in mammary lobes (Fig. 5.1B).  However, mammary tissue 
of pIgR deficient dams still contained conglomerates of IgA-secreting plasma cells which were 
able to expel IgA into the lactiferous ducts.  Over the course of nursing, both dam genotypes 
provided IgA to their offspring (Fig. 5.1C) which was found in pup stomachs (Fig. 5.1D), but 
only IgA with secretory component attached (SIgA) was able to traverse the entire neonatal GI 
tract (Fig. 5.1E) and be found in stool samples (Fig. 5.1F).  These observations are supported by 
the findings that SIgA is more resistant than IgA to proteolytic degradation by the digestive 
enzymes trypsin and pepsin (283).  Before and directly after weaning, mouse IgA+ plasma cell 
numbers in the intestine are low (Fig. 5.1G), so the neonate’s only source of SIgA is provided by 
maternal milk (Fig. 5.1F).  These observations were completely dependent upon maternal ability 
to provide SIgA, and were not affected by offspring pIgR genotype.  As mice age, the number of 
IgA+ plasma cells increases in density along the length of the colon (Fig. 5.1G).  Though no 
differences were seen in absolute numbers of IgA+ cells between all offspring from breeding 
scheme, we found significantly less IgA in the stools of adult offspring from pIgR deficient dams 
(Fig 5.1H). 
 Neonates not receiving passive SIgA show greater bacterial translocation to MLNs 
of opportunistic pathogen Ochrobactrum anthropi.  Infant intestines become less permeable 
as the child ages (284), but a constant threat during the first stage of life is the possibility of 
bacterial diffusion across the intestinal epithelium into the soma proper.  We found that in mice, 
bacteria were in very intimate contact with the colonic epithelium during the first few weeks of 
life (Fig. 5.2A).  This remained consistent regardless of dam or pup Pigr genotype.  Likely for 
this reason, we occasionally found culturable anaerobic bacteria (colony-forming units, CFUs) in 
the MLNs of the four types of breeding scheme offspring (Fig. 5.2B).  However, aerobic bacteria 
were only found once in pups receiving passive SIgA, and were almost always found in pups not 
receiving passive SIgA.  Upon visual inspection of aerobic bacteria culture plates, a predominant 
colony morphology was seen from all mice not receiving passive SIgA.  This colony was isolated 
and the genome region for the 16S rRNA sequenced.  BLAST alignment to all known bacterial 
16S rRNA genome sequences showed high sequence alignment (99%) to Ochrobactrum anthropi 
(Fig 5.2C), an opportunistic pathogen in humans.  Interestingly, O. anthropi has only been 
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identified as a potential pathogen in the past two decades, has been associated with infant 
bacteremia and peritonitis (285, 286), and is known to carry a potent LPS (287).  Total 16S rRNA 
signal from pup fecal samples showed no differences in the prevalence of the Ochrobactrum 
genus within the intestines of the neonates.   
 Infant and adult microbiota is heavily dependent upon receiving passive SIgA 
during nursing.  To investigate the effect of passive SIgA on the intestinal microbiota, we 
compared neonate and adult fecal microbiotas from the offspring receiving and not receiving 
SIgA during nursing.  Stool samples were taken at the day of weaning (21d after birth) and every 
following five days until the mouse was 70d old.  Analysis of total bacterial DNA in stool 
samples showed bacterial quantities in a much more similar pattern based upon maternal Pigr 
genotype compared to offspring genotype (Fig 5.3A).  Significantly higher amounts of bacterial 
DNA were found in stool samples from offspring receiving passive SIgA at 21 and 31 days of 
age.  Upon real-time qPCR analysis of the community dynamics for the four dominant bacterial 
phyla in mammalian intestines (Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria), all 
four phyla were detected at each timepoint from the four types of mice from the breeding scheme 
(Fig. 5.3C).  Phylochip microarray analysis was also performed on isolated bacterial DNA from 
selected samples.  Only the fecal microbiota of offspring with the ability to produce active SIgA 
(Pigr +/- offspring) was surveyed.  Two samples were taken from each mouse, one at 21d after 
birth and one at 70d.  Microarray analysis further confirmed the stability of phyla presence over 
the 21d to 70d timecourse measured, with no significant differences in representation of the four 
dominant bacterial phyla regardless of the age of the mouse or the mouse’s ability to receive 
passive SIgA (Fig. 5.3B).  Though diversity of bacterial phyla did not differ throughout time or 
reception of passive SIgA, diversity at the species level was widely apparent, and principal 
component analysis of OTU presence/absence data closely clustered by maternal Pigr genotype 
early and later in the life of the mouse (Fig. 5.3 PCoA plot and adjacent dendogram).  In fact, 
hierarchical clustering of the groups showed the greatest distance to be between the two adult 
groups which were only separated by receiving or not receiving passive SIgA during nursing.  
This data suggests a possible mechanism for long-lasting effects of initial gut microbial 
establishment by SIgA long after the animal has been separated from maternal contact and SIgA 
provision.   
Human milk is the most efficient prophylactic against many neonatal intestinal 
inflammatory diseases, including infant enteritis and NEC (282).  Many bacteria are early 
colonizers of the intestinal tract that have the capacity to become opportunistic pathogens, 
especially if the infant is pre-term or in an immunocompromised state.  Several of these 
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opportunists have been identified from the bacterial genera Clostridium, Klebsiella, Enterobacter, 
Pseudomonas, and Staphylococcus (288).  Using the phylochip survey of the entire 21d weanling 
microbiota, we saw consistent increases in many OTUs within each of these genera in the fecal 
microbiota of neonates not receiving passive SIgA (Fig. 5.3E).  Significant increases in 
abundance (p < 0.05) were seen with specific OTUs within the genera Staphylococcus and 
Enterococcus.  Though weanlings not receiving passive SIgA did not display overt signs of 
spontaneous intestinal inflammation, these increases in Staphylococcus, Klebsiella, and 
Enterobacter are also mirrored in human infants within days of NEC diagnosis (289).  In 
addition, we also found greater changes in OTU abundance from weaning to adulthood of 
offspring not receiving passive SIgA (Fig. 5.3F).  These findings promote the idea that SIgA in 
maternal milk positively affects the offspring microbiota by subduing abundance of opportunistic 
pathogens and promoting a more stable community that is less susceptible to perturbations over 
time. 
Adult CEC gene expression patterns more dependent upon passive SIgA than active 
SIgA. Gene expression in colonic epithelial cells (also, CECs) is known to be directly influenced 
by bacterial products that can signal to the epithelial cell through pattern recognition receptors 
(PRRs) and short chain fatty acids (SCFAs) (46, 63).  Our survey of intestinal microbiotas 
showed unique bacterial communities in adult mice which were dependent upon receiving passive 
SIgA as neonates.  To further characterize changes in CEC gene expression in adult mice, we 
isolated CECs from adult mice generated from the breeding scheme (Fig. 5.1A) treated with or 
without DSS to cause acute colitis.  Figure 5.4 shows the results of microarray analysis from 
these different cohorts of mice with segregations by factor interactions or statistical significance.  
As expected, DSS-induced colitis had the most profound effect on CEC gene expression, but 
passive SIgA showed a much more substantial effect compared to active SIgA (Fig. 5.5A,B).  
Using Reactome biological pathway overrepresentation analysis (www.reactome.org) for 
significantly up- and downregulated genes by our experimental factor(s), we again found DSS as 
having the greatest effect on overrepresentation of genes which map to specific biological 
pathways (Table 5.1).  However, both by itself and in synergy with DSS treatment, passive SIgA 
showed profound ability compared to active SIgA in its ability to change gene expression that 
maps to precise biological pathways.   
In humans, approximately 100 gene loci are known to be associated with the prevalence 
of inflammatory bowel diseases (IBDs) and 40 are known to associate with coeliac disease (290, 
291).  In our experiments, we found CEC gene expression of the putative genes within these 
known susceptibility loci to be highly dependent upon the colitic agent DSS, but also greatly 
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influenced by the synergy between passive SIgA and DSS (Table 5.2).  While DSS treatment 
modulated genes within all four categories of intestinal inflammation, we found that gene 
expression significantly changed by the combination of DSS and passive SIgA grouped into only 
the categories of Crohn’s and coeliac disease.   
We validated many genes from our microarray results by Nanostring nCounter analysis, 
which quantifies the actual number of mRNA copies within a sample for a given gene.  We chose 
40 candidates in which to validate the gene expression trends we saw from the microarray 
analysis (Table 5.3).  Using mRNA abundance for our different treatment groups, we applied the 
variable reduction power of principal component analysis (PCA) in order to plot the different 
treatment groups according to gene expression pattern of validated genes.  We found clear 
separation of mean PCA values from the treatment groups (n=6 mice per group) with and without 
exposure to DSS (Fig. 5.6A).  A more subtle, but clearly distinguishable and statistically-
significant separation also occurred between groups receiving and not receiving passive SIgA.  
Presence or absence of active SIgA did not lead to group segregation.  These data further point to 
the effect of receiving passive SIgA as a neonate on CEC gene expression patterns in adult 
animals.  Blinded pathological scoring of colon sections showed a strong negative correlation 
between pathology score and principal component 1 (PC1), but no correlation with PC2 (Fig. 
5.6B).  With the exception of DSS administration, mouse treatment groups did not show any 
significant differences in disease activity index (DAI) (Fig. 5.6C) or colonic length (Fig. 5.6D) at 
time of sacrifice, suggesting that changes due to passive and active SIgA occurred more at the 
cellular and transcriptional levels.   
 
SUMMARY                    
The human infant is born immunodeficient, and relies on the extra-uterine link the mother 
supplies through breastmilk (80).  Here, we present data from the mouse model showing neonates 
not receiving SIgA during nursing as having increased translocation of the opportunistic pathogen 
Ochrobactrum anthropi to mesenteric lymph nodes (Fig. 5.2B,C).  Furthermore, these mice have 
an intestinal microbiota that is unique from SIgA-fed neonates (Fig. 5.3D) with higher abundance 
of many bacteria that are opportunistic pathogens in human (Fig. 5.3E).  The effects of not 
receiving passive SIgA during nursing extend well after mice have reached adulthood, as shown 
by lower fecal IgA levels (Fig. 5.1H), high degree of OTU-specific abundance shifts since 
weaning (Fig. 5.3F), and an intestinal microbiota dramatically different from their passive SIgA-
receiving cohorts (Fig. 5.3D). In adult mice, receiving SIgA early in life had a more profound 
effect on CEC gene expression than the ability of the mouse to produce active SIgA by itself (Fig. 
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5.5A,B).  Mice producing active SIgA and receiving passive SIgA during nursing had similar 
responses to DSS-induced acute colitis in disease presentation (Fig. 5.6), but showed unique CEC 
gene expression patterns with or without DSS treatment (Fig. 5.6A).  By incorporation of adult 
CEC gene expression data into biological pathway overrepresentation analysis, we found passive 
SIgA to have a much greater effect over active SIgA on intracellular biological pathways affected 
by its presence (Table 5.1). 
An interesting finding of this study was that dams deficient for the pIgR protein were still 
able to transmit IgA to their pups through milk (Fig. 5.1B,C).  Though this IgA was found in pup 
stomachs (Fig. 5.1D), when lacking the secretory component, it is presumably degraded in the 
neonatal intestine by digestive enzymes (283) and never reaches the colonic lumen (Fig. 5.1E,F).  
Maternal milk is the only available source of SIgA in the neonatal mouse, as pIgR-sufficient 
offspring showed undetectable SIgA levels if they were being nursed by a pIgR-deficient dam 
(Fig. 5.1F).  By mass, 4% of human colostrum and 0.1% of mature milk is composed of the 
protein secretory IgA (17).  For the enormous amount of energy the nursing female body devotes 
to the production and transfer of this bioactive protein, we now show multiple mechanisms by 
which this metabolic effort may assist in the development and lifelong fitness of the offspring.          
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Figure 5.1. Neonates fed secretory IgA, but not IgA, in breastmilk have IgA in intestinal lumen.  
A) Breeding scheme allowing both Pigr +/- and Pigr -/- mice to be generated from a Pigr +/- or Pigr 
-/- mother.  B) Sections of mammary tissue extracted from breeding scheme dams 10d postpartum 
and stained with H&E and serial section with antibody against mouse-pIgR (Rhodamine, red), 
mouse-IgA (FITC, green), and counterstained to visualize nuclei (DAPI, blue).  Lower panels are 
enlarged section of hashed box in upper panel.  White arrows in lower panels indicate 
concentrations of IgA-secreting plasma cells localized in mammary.  Lactiferous ducts denoted 
by ‘LD’ and representative lobes by ‘L’.  Scale bar =50µm for all panels.  C) IgA content of milk 
from nursing dams (mean ± SEM, n=3-6 milk samples from 2-4 dams/timepoint).  D) IgA content 
of neonate stomach contents at 10d (mean ± SEM, n=3-15 stomach contents from multiple 
litters).  E) Sections of 10d-old neonate colon and luminal space stained for IgA (FITC, green) 
and nuclei (DAPI, blue).  White line denotes apical surface of colonic epithelium with colonic 
lumen above and epithelial cells below.  Images representative of both pup genotypes for the 
given maternal genotype.  Scale bar = 50μm.  F) Fecal IgA levels of neonates around time of 
weaning (mean ± SEM, n=3-21 stools from multiple mice and 3-5 litters).  G) IgA+ plasma cells 
in colon from D10, 21, 30, and 70-old mice.  White arrows indicate visible plasma cell. Images 
representative of both offspring genotypes from both maternal genotypes at given timepoint. 
Scale bar = 50μm.  H) Adult fecal IgA levels from mice generated by breeding scheme (mean ± 
SEM, n=11-13 stools from multiple mice and multiple litters).        
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Figure 5.2. Neonates not receiving passive secretory IgA show translocation of the opportunistic 
pathogen Ochrobactrum anthropi to mesenteric lymph nodes.  A) Day 10 and 21 neonate colons 
showing direct bacterial contact with epithelium as visualized by fluorescence in situ 
hybridization (FISH) for bacteria (Cy5, pink), immunofluorescence for IgA (FITC, green), and 
counterstaining to visualize nuclei (DAPI, blue).  White dotted line indicates boundary between 
epithelium and colonic lumen. Images representative of both pup and both maternal genotypes at 
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given timepoint. Scale bar = 50μm.  B)  Quantification of culturable anaerobic and aerobic 
bacteria in MLNs of 21d neonates.  Data represented on a log10 scale as mean ± SEM (n=6-15 
mice from 3-4 litters).  C) BLAST sequence alignment of purified DNA from primary aerobic 
bacterium isolated from 21d offspring of Pigr -/- dams aligned to Ochrobactrum anthropi genome 
segment 228910 through 229104.  Sequences show 99% identity. D) Day 21 neonate fecal 
prevalence of Ochrobactrum genus as measured by 16S rRNA signal.  Data represented as mean 
± SEM, n=5.   
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Figure 5.3.  Composition and stability of intestinal microbiota is highly dependent upon 
receiving passive SIgA during suckling.  A) Total bacterial density per stool pellet as measured 
by real-time qPCR.  Mice from SIgA-sufficient dams shown by solid bars and from SIgA-
deficient dams in hashed bars.  Stool densities more similar between mice with same maternal 
genotype compared to mice with same Pigr genotype.  Statistically-higher bacterial numbers for 
mice from SIgA-sufficient dams at days 21 and 31.  Data represented as mean from n=4-9 fecal 
samples from 2-3 litters per timepoint. *, p < 0.05 comparing maternal genotypes.  B) Phylochip 
microarray analysis of phyla richness for mouse stool samples from both maternal and both 
offspring genotypes (5 for each group).  ‘W’ denotes 21d weanling, ‘A’ denotes 70d adult mouse. 
C) Real-time qPCR analysis of fluctuations from weaning at 21d of age to 70d in relative 
percentages of fecal bacteria within four dominant phyla of intestinal bacteria. (Firmicutes, 
Bacteroidetes, Proteobacteria, Actinobacteria). Data represented as mean from n=4-9 fecal 
samples from 2-3 litters per timepoint.  D) Phylochip-derived principal coordinate (PCoA) 
analysis of mouse fecal samples by unweighted Unifrac presence/absence data showing fitted 
clustering of the four experimental groups and separation between weanling and adult samples.  
Dendogram to right shows hierarchical clustering of samples displayed on PCoA plot. PCoA1 
explains 27% of varience and PCoA2 explains 22%. E) Signal strength from phylochip 
microarray for 21d weanlings for species associated within genera implicated in necrotizing 
enterocolitis (NEC): Staphylococcus (S. aureus, S. epidermidis, unclassified S.), Enterococcus (E. 
lactis, E. casseliflavus, E.haemoperoxidus, E. asini, E. durans, E. faecalis, E. cecorum), 
Klebsiella (K. oxytoca), Pseudomonas (P. anguilliseptica, P. citronellolis, P. umsongensis), 
Clostridium (Clostridium perfringens). F) Change in OTU abundance by phylum of fecal 
microbiota from paired samples from mice at 21 and 70d.  Bar numbers indicate quantity of 
OTUs within given phylum with highly significant change (P < 0.01) in abundance from age 21d 
to 70d. 
 
 
 
 
 
 
 
 
98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.  Flow chart for 35,557 probes in mouse gene expression microarray for isolated 
colonic epithelial cells from 8-10 week adult offspring from breeding scheme (Fig. 5.1A) with or 
without DSS treatment.  Probes assort into bins depending upon depending on high statistical 
significance (‘Yes’ or ‘No’) of indicated factor or multifactor interaction.  Analyses for this study 
focused on genes with 1 way interaction p-value < 0.01, for three independent factors in this 
study (lower right of flow chart).      
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Figure 5.5. Receiving passive secretory IgA during suckling has more profound effect on colonic 
epithelial cell gene expression in adult mice than production of active secretory IgA. A) 
Proportional Venn diagram showing microarray analysis for each factor with quantities of highly 
significant (p< 0.01) changes in gene expression by 1 way interaction (see flow chart, Fig. 5.4). 
B) Volcano plots for each variable showing increases or decreases in gene expression with highly 
significant 2 way interaction (p < 0.01).  y-axis plotted on log10 scale and x-axis on log2 scale.   
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Table 5.1: Indicated factor(s) upregulation (red) or downregulation (green) of genes with highly 
significant (p < 0.01) representation in biological pathway 
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Table 5.2: Known Human Gene Polymorphisms Associated with IBDs and Coeliac Disease that 
were Significantly Changed (p < 0.01) by Indicated Factor(s) (See Fig. 5.5A)   
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Figure 5.6.  Colonic epithelial cell gene expression during experimental colitis more dependent 
upon receiving secretory IgA during suckling than ability of mouse to produce active secretory 
IgA. A) PCoA clustering of colonic epithelial cell gene expression, as determined from 
Nanostring nCounter survey, from 8-10week adult mice in breeding scheme with or without DSS 
treatment (n=6 per group).  Analysis of variance table shows significant changes in both principal 
coordinates with respect to maternal genotype and DSS treatment, but not mouse genotype.  B) 
Strong negative correlation of PCoA1 with microscopic pathological scoring of mouse colons  C) 
Disease activity index (also, DAI) of mice during DSS regiment based on summation of scores 
for weight loss, stool consistency, and presence of occult or visible blood (1). No significant 
differences between maternal or offspring genotype for each timepoint.  Data represent mean of 
n=8-15 mice from 5-8 litters per timepoint. D) Colon shortening as a result of DSS treatment 
(mean ± SEM, n=8-15 mice from 5-8 litters per timepoint).        
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Chapter 6 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
The human body employs numerous redundant mechanisms in which to sense the 
bacterial inhabitants within the GI tract.  These microbial colonizers are with us from the first 
seconds of life and persist in our bodies until we perish.  This colonization is a potentially 
advantageous event for both host and immigrant.  The immigrant benefits through the habitation 
of a niche environment which is rich in nutrients, warm, and at low oxidative stress.  The profits 
gained by the human host are much more relevant in the field of the medical sciences and have 
multiple known avenues: higher caloric intake, stimulation of innate immune effectors, assisted 
maturation of the adaptive immune system, and colonization resistance of pathogens (162).  With 
recent elucidation of the benefits exchanged between the two parties, their relationship 
nomenclature is quickly shifting from ‘commensal’, meaning two that eat from the same table 
(292), to ‘mutualist’, indicating exchanged services between the different organisms (96, 293, 
294).  Poor or contentious communication between these two parties is detrimental to both host 
and mutualist, and can quickly lead to the death of both organisms.  
   Along the entire length of the GI tract, microbes or their metabolic products first come 
into contact with the host at the GI epithelium.  For this reason, the epithelial cell has the 
important role of being the “first responder” to microbial presence and deciding what actions to 
take not only for itself and other contiguous epithelial cells, but in the production of molecules 
that will affect both host and microbiota.  The work presented in this dissertation focuses on 
mechanisms used by this cell type to appropriately respond to the continual company of bacteria 
at the oral and intestinal epithelium.  We expound and add information to well-known 
mechanisms of recognition such as modulation of epithelial gene expression and cytokine 
secretion by bacteria and their products.  Novel biological phenomena pertaining to mucosal 
immunology are also presented which include: inhibition of NF-κB signaling in oral epithelial 
cells by the hormone adiponectin, lowered expression of AdipoR2 in inflamed IBD patients’ 
intestine, changes in crypt localization of epithelial pIgR expression patterns along the length of 
the colon, meticulous localization of the immune proteins SIgA and SC in the colonic outer 
mucus layer, necessity of SC binding to IgA in milk for transit through the entire GI tract,  SIgA 
in hindrance of Ochrobactrum anthropi translocation to neonatal MLNs, a unique microbiota 
consortium as neonates and adults depending upon receiving passive SIgA, and maternally-
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supplied passive SIgA and a stronger moderator of adult CEC gene expression versus 
endogenously-produced active SIgA.         
Bacterial-induced regulation of intracellular signaling pathways, gene expression, 
and production of immune molecules in the epithelial cell.  The current paradigm of the 
epithelial innate immune response to bacteria hinges around the concept of PRR-induced 
recognition of the microbe and the resulting activation of intracellular signaling pathways (46, 49, 
295). Humans (296-298) and animals (299-301) deficient for these very basic bacterial 
recognition systems consistently present with increased susceptibility to excessive inflammation, 
especially at high bacterial-density mucosal sites along the GI tract.  The direct microbial etiology 
for these inflammatory states is further supported by the antibiotic standard of care, which aids in 
amelioration of inflammation.  Moreover, transgenic animals that would be susceptible to 
hyperinflammation under conventionally-raised conditions reliably show mitigated inflammation 
when reared under germ-free conditions (96, 150).  But unabated inflammation is simply one way 
in which the host can inappropriately respond to the microbe.  When reacting to microbial 
presence, the opposite of overreacting with injurious inflammation is not reacting at all.  Severely 
immunocompromised humans and laboratory animals become systemic culture tubes for 
opportunistic bacteria and display strong predilections for bacteremia and associated infections 
(302).  We propose a novel mechanism potentially utilized by human CECs in vivo in order to 
neither simply promote nor discourage a response to MAMPs from commensal bacteria.  Because 
resident bacteria need to be responded to, but not overemphasized, we are labeling this 
phenomena as the “appropriate inflammatory” response.  The molecule responsible for the 
initiation of the appropriate inflammatory response is the adipokine adiponectin, which is found 
at relatively high levels in human systemic circulation in the oligomerized high-molecular weight 
(HMWAd) form (169).  By itself, HMWAd had little effect on human oral and intestinal 
epithelial cell lines, but in combination with multiple types of bacterial products which were 
capable of activation of multiple TLRs, the epithelial cells showed significant increases over sole 
TLR stimulation in gene expression and secretion for many pro-inflammatory cytokines and 
chemokines.  In addition, the host-derived cytokine TNF was also able to synergize with 
HMWAd-induced signaling to further increase inflammatory gene expression and cytokine output 
over either of the stimulants alone.  Similar findings of HMWAd as showing a pro-inflammatory 
nature has been seen in other human cell types (122, 123).  At the epithelial interface, TNF is 
readily generated through PRR signaling, so HMWAd induction of the inflammatory response 
can be beneficial for the host, in the quick and sensitive detection and response to pathogenic or 
mutualistic microbes and their products.  Concurrent with the increase in pro-inflammatory 
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mediators, the combination of TLR ligands and TNF with HMWAd and simply HMWAd by 
itself was able to increase production of molecules that function to shut off inflammatory 
signaling within the cell.  Most strikingly in oral epithelial cells, gene expression of A20, which 
stymies the NF-κB heterodimer from entering the nucleus and inducing gene transcription, was 
increased by orders of magnitude with stimulation with HMWAd alone, or in combination with 
LPS or TNF.  The NF-κB reverse shuttling protein, PPARγ was also found to be at significantly 
higher levels in intestinal epithelial cells following combined HMWAd and LPS stimulation.  
Data from other groups correlating low human serum levels of HMWAd with increased systemic 
presence of pro-inflammatory molecules in humans (210, 212, 303) shows the potential causative 
nature of one event leading to the other.  In our experiments, we specifically saw the increase of 
NF-κB inhibitors in oral epithelial cells lead to reduced capacity of long-term continuation of the 
NF-κB signaling cascade.  As copious research has shown the NF-κB pathway in the regulation 
of both pro- and anti-inflammatory signaling in epithelial cells (53), and since adiponectin 
receptors, TLRs, and the TNF receptor all utilize the NF-κB signaling cascade, perhaps continual 
intracellular interplay and pathway formatting exists when two or more of these receptor types are 
activated at the same time.  Though tremendous increases in expression of A20 were seen in oral 
epithelial cells, we cannot exclusively attribute the decrease in NF-κB activity to this single 
regulator.  Negative feedback in the CEC by the combined stimulation of adiponectin and Toll-
like or TNF receptors could take numerous other forms.  Future experiments should investigate 
expression levels for TLRs and TNFR1 following HMWAd pretreatment of the cells, since lower 
quantities of these receptors could lead the epithelial cells to more of an ‘immune ignorant’ state.  
We did not observe changes in expression of the two putative adiponectin receptors to our 
stimulants in vitro, but this does not rule out in vivo occurrence of this event.  Additionally, the 
multitude of immune signaling regulators for TLRs (MyD88s, IRAK-M, TOLLIP, SIGGR, SOCS 
proteins) (56), TNFR1 (ARTS-1, TRAF1) (304, 305), and general NF-κB regulators (PI3K 
signaling, NIK, IKK-γ) (306) should also be assayed for abundance and intracellular activity. The 
concentrations of the stimulants used in this study were based upon normal physiological 
concentrations of HMWAd and typical amounts of TLR and TNFR ligands used for cell culture 
experiments.  While we made concerted efforts to not present data on stimulatory (or inhibitory) 
capacity based upon variable concentrations, this is not representative of biological situations 
where HMWAd, TNF, and bacterial products are constantly in flux with proximity to epithelial 
cells.  Variable concentrations of all three of these cell stimulants as well as time points for 
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stimulant exposure would give valuable information on the dynamics of physiological outcomes 
for different situations the host epithelium may be placed in.   
Adiponectin was initially defined as a metabolic hormone in the late twentieth century 
with the striking finding that patients presenting as obese with or without metabolic syndrome 
comorbidity showed paucity of the protein in serum (307).  This sole paradigm for adiponectin 
function persisted, even after the creation of a knockout (KO) mouse less than a decade ago 
(308).  Only in the past few years has the adiponectin KO mouse been utilized for immunological 
studies, almost exclusively in the field of intestinal immunity (139, 141-143).  Future experiments 
should selectively analyze epithelial cells along multiple bacteria-inundated sites of the GI 
epithelium in the adiponectin KO mouse to see if discriminatory activation or inactivation of 
inflammatory pathways occurs in the presence/absence of bacteria (even inoculation with specific 
mutualists or pathogens) when the animal lacks the adiponectin protein.  In addition, our 
experiments clearly showed the abundant presence of both adiponectin receptors along the human 
GI epithelium, but selective downregulation of AdipoR2 in the inflamed colonic epithelium of the 
IBD patient.  Our data showed statistical significance for AdipoR2 downregulation in both 
Crohn’s Disease and ulcerative colitis patients, but we failed to assess protein levels for this 
receptor or other intracellular signaling molecules linked to adiponectin signaling.  In addition, 
we also worked with a geographically homogenous patient population, and had a relatively low 
number of patients recruited for this study.  Epidemiological studies should seek to assess if 
correlations exist between uncontrolled inflammatory events and the absence of HMWAd or its 
receptors in humans, especially if the state of inflammation is known to have at least a partial 
bacterial origin.        
 Depending on the contemporary working definition of bacterial species (also, OTU and 
phylotype), between 500 and 20,000 unique bacteria inhabit our intestinal tracts (309).  In 
Chapter 4, we investigated the responsiveness of intestinal epithelial cells to an assortment of 
these microbes from the four dominant phyla which inhabit the GI tract.  The HT-29 human 
intestinal epithelial cell line was selected for our studies due to its prolific use as a model of 
intestinal epithelial cells and its well-known regulation of pIgR production (57, 264, 265, 269).  
Using eight different species found regularly in human intestines and one pathogen, we found 
very few bacteria were able to stimulate gene expression and chemokine release from the HT-29 
intestinal cells.  In fact, of all bacteria used, only species within the family Enterobacteriaceae 
were able to provide any profound stimulation of gene expression in the HT-29 cell line, and 
constituted the majority of increased gene expression in another human intestinal epithelial cell 
line, CaCo-2 cells.  While not a complete representation of intestinal epithelial cells in a higher 
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vertebrate, the common trend of unique bacteria being emphatically recognized by multiple 
intestinal cell lines points to a recognition priority of certain bacteria over others.  Both the 
mutualist E. coli and pathogenic S. typhimurium share very common ligands for Toll-like 
receptors, including a hexyl-acetylated Lipid A moiety on their LPS (strong ligand for TLR4) and 
flagellin with TLR5 stimulatory capacity (47, 310).  Multiple human enteric pathogens reside 
within the Enterobacteriaceae family (311), so it may be an evolutionary result of the default host 
survival mechanism for the intestinal epithelium to be able to quickly respond to interaction with 
bacteria from this group, whether friend or foe.  The phenomena of endotoxin tolerance through 
PRR signaling relates to the concept of common mutualist/pathogen recognition by the host and 
may explain why mutualistic Enterobacteriaceae can be readily found in the oral and intestinal 
microbiota.  Upon prolonged stimulation of PRRs, fresh receptor ligands are unable to elicit the 
magnitude of response at the transcriptional level as naïve cells seeing the stimulants for the first 
time (312, 313).  Many of these “tolerizable” genes are pro-inflammatory, while “non-
tolerizable” genes that are continually produced regardless of duration of PRR stimulation include 
many anti-inflammatory genes as well as AMPs (314, 315).  It would then be advantageous to the 
host to foster a regulated population of Enterobacteriaceae lacking virulence factors, but still 
retaining MAMPs which would “tolerize” pro-inflammatory gene expression so excessive 
inflammation does not occur upon introduction of Enterobacteriaceae pathogens.  This gives 
credence to the manufacturing of probiotic Enterobacteriaceae, such as E. coli strain Nissle 
(316), but due to inadequate education, the public’s mind must change before their intestines can. 
 While the Enterobacteriaceae were strongly recognized by intestinal epithelial cells, the 
majority of other bacteria used in the study were seemingly ignored by the eukaryotic cells in 
both pro- and anti-inflammatory gene expression.  In addition, when we performed co-stimulation 
experiments with EcN in combination with another mutualist, we found no significant changes in 
pIgR or Il-8 gene expression over EcN stimulation alone.  Of course, this does not accurately 
represent the intestinal environment where hundreds if not thousands of bacteria and their 
MAMPs would be in close contact with the epithelial cell.  Immune cells would also be in close 
proximity with the epithelial cell along the entire length of the GI tract.  When stimulating the 
human THP-1 monocyte cell line with the same bacteria used for the HT-29 cells, we saw the 
ability of a more professional immune cell to respond to all bacteria used, regardless of phyla.   
With our epithelial cells, we also did not perform any repeated stimulations in this experimental 
model, so perhaps initial treatment with commensal(s) followed by stimulation with 
Enterobacteriaceae would show differing, and possibly more subdued gene expression patterns.  
For our study, a very limited number of genes were assayed for changes in expression, and more 
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thorough efforts have been made by other groups to characterize the stimulatory capacity of other 
mutualistic bacteria.  However, the genes selected for our research are known to be some of the 
more important effectors produced by the intestinal epithelial cell.  Specifically, the pIgR gene is 
almost exclusively expressed along the body’s epithelia, which apparently correlates with higher 
vertebrates’ necessity for IgA and IgM transport across the low-permeability epithelial barrier 
(99).  However, pIgR orthologs have been found to be more evolutionarily ancient than IgA, so it 
is probable that pIgR not only plays a role in other Ig isotype transport, but also in other innate 
immune functions (112, 317).  Consistent with previous findings from our group and others, 
elevated pIgR expression in intestinal epithelial cells required continuous, prolonged stimulation 
(255).  We found that Enterobacteriaceae were unable to highly-upregulate pIgR expression if 
only in contact with epithelial cells for 3h, regardless if the epithelial cells were harvested 
immediately or 21h after contact with bacteria.  This mirrors the situation within the host, where 
bacteria and their MAMPs are continuously present, thus continually promoting robust pIgR 
expression in the epithelium.  If these products from Enterobacteriaceae had a strong affect upon 
pIgR production in vivo, it would be predicted that differential pIgR expression patterns on the 
underlying epithelium would be seen in connection with the overlying resident 
Enterobacteriaceae population.  Our visualization of crypt pIgR expression in different locations 
of the colon showed a direct connection between pIgR expression on the apical crypt cells nearest 
the microbiota and the amount of resident Enterobacteriaceae (9, 38).  In areas with fewer 
amounts of these bacteria, CECs producing pIgR were generally found in the middle or at the 
bottom of the crypt, indicating a mechanism of constitutive expression which may be independent 
from MAMP-induced signaling.  Crypt apical epithelial cells will have the greatest access to 
Enterobacteriaceae MAMPs by their simple diffusion through the mucus layer.  However, the 
CECs lining the deeper parts of the crypts will experience much less MAMP exposure due to the 
constricted nature of the crypt and the unidirectional flow of mucus continually pushing crypt 
contents into the colonic lumen. Being that this is a novel finding, this same imaging should be 
performed in germ-free mice to see the crypt pIgR localization patterns.  Unfortunately, germ-
free mice have altered crypt architecture (318), so interpretation of results might be difficult.  
Additionally, gnotobiotic mice which have been monocolonized with a single bacterial 
phyla/species/etc. might give additional information to the in vivo importance of the particular 
taxa on CEC pIgR patterning.              
 Localization of pIgR-derived products in the colonic mucus.  With the recent advent 
of new tissue fixation methods and improved techniques, researchers are now able to see 
molecules, proteins, and cells in situ as never before.  For our purposes, Carnoy’s fixative 
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allowed preservation of the colonic mucus layer which would have normally been dehydrated by 
aldehyde-based fixatives (35).  Conventional wisdom has assumed the distribution of SC, IgA, 
and SIgA throughout the mucus layer as providing a buffer zone to impede further bacterial 
migration through the mucus and contact with the epithelium (110, 149).  We found SC, IgA, and 
SIgA all in high densities in only the outer mucus layer of mice.  Similar imaging in human 
biopsies showed the same phenomenon of IgA migration to the outer mucus layer after departure 
from the epithelial cell.  Of course, these immune molecules are forced to transit from the 
epithelial surface to the outer mucus layer by passing through the inner layer.  In mouse colons, 
this was not visibly seen, likely due to the low production of IgA as a result of living in a sterile 
environment.  However, when imaging human colon sections, a clear differentiation in color is 
seen between goblet cells secreting fresh mucus, and the mucus which has been in the lumen for a 
longer period of time.  The lighter shade of the more aged mucus is likely due to diffuse IgA 
throughout the inner mucus layer which has not concentrated yet.  Manual separation of the two 
mucus layers is possible, and proteomic analysis of the two layers has been published and shows 
IgA and SC in both layers (36, 244).  However, direct quantification of these proteins in the two 
regions is not known and could further illuminate this discipline. 
    Our finding of the outer mucus-localization of these immune proteins immediately 
points to the other entity which inhabits this layer: the intestinal bacteria.  Many other groups 
have shown the bacterial segregation to the outer mucus layer which we were also able to repeat 
in this study.  Though SC, IgA, SIgA, and bacteria were all present in very high concentrations in 
the outer mucus layer, our findings using the Pigr -/- mouse showed that bacteria do not gain 
increased access to the inner mucus layer or the colonic epithelium in the absence of all three 
immune molecules.  Again, these studies were performed in mice reared under mostly sterile 
conditions, so a heavier bacterial presence with the occasional pathogen may show more of a 
necessity for pIgR-derived products in bacterial exclusion.  Studies in humans deficient for IgA 
are lacking, but inability to produce IgA is one of the most common immunodeficiencies and is 
many times asymptomatic (319).  Individuals with this condition are more susceptible to recurrent 
bacterial infections along mucosal surfaces, especially in the upper respiratory tract (320).  
Infection studies have shown increased access of enteric pathogens to the epithelium and host in 
Pigr -/- mice (321), and amelioration of pathogen burden with the passive supplementation of IgA 
(322).  Further infection studies should be performed to determine if this SIgA/SC protection 
strategy is pathogen-specific.           
 At birth, neonates are in a state of immunodeficiency due to their underdeveloped 
adaptive immune system.  In nature, this is remedied by maternal supplementation of numerous 
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immune factors through the milk (80, 282).  Both SC and IgA are at voluminous concentrations in 
colostrum and substantial amounts in mature milk, suggesting considerable biological importance 
for these proteins in the infant.  The IgA+ PCs in the mammary glands are immigrants from the 
intestinal mucosa, and secrete IgA that is polyclonal in nature for the intestinal microbiota (323).  
In our experiments, we observed that mouse neonates were unable to produce detectable amounts 
of IgA in stool samples until around 30 days after birth, likely because of the IgA+ PC dearth.  
These low IgA levels are also seen in human infants (324), with a 3x-increase in fecal IgA of 
breastfed versus formula-fed neonates (325).  During nursing, we found that neonates receiving 
passive SIgA showed complete transit of this molecule to the distal GI tract.  However, IgA by 
itself was unable to make the complete GI voyage, assumedly due to degradation by digestive 
enzymes in the proximal intestine.  Connecting the evidence that the maternal IgA+ PCs in the 
mammary are secreting bacteria-directed antibodies, and that infants are unable to produce robust 
IgA responses, it is quite reasonable to assume maternally-supplied SIgA is going to have an 
effect on the intestinal microbiota.  We found this to be the case in our experiments, with multiple 
analyses of the young mouse showing the palpable effect of presence (or absence) of passive 
SIgA.  These two cohorts of mice each had unique microbiotas which were tightly grouped 
according to passive SIgA status.  Around the time of weaning, the mice receiving passive SIgA 
had higher numbers of fecal bacteria and lower numbers of many bacteria within genera known to 
be a contributing factor to necrotizing enterocolitis (289).  One of the most profound differences 
between these two groups of mice was the consistent presence of Ochrobactrum anthropi in the 
MLNs of the neonates not receiving passive SIgA.  Again, this points to the maternal 
supplementation of SIgA as having inhibitory effects of opportunistic bacteria residing in the 
immature neonatal intestine.  Human breastmilk is the best known remedy for prevention of NEC, 
though the direct inhibitory action of SIgA (or other milk antimicrobial molecules) has not been 
solidified as the prophylactic factor(s).                                    
 Consequences of an absent intestinal mucus layer.  One of the hallmarks of intestinal 
health is the ability to keep bacteria segregated from the epithelium (149, 326).  Many enteric 
pathogens are aware of this, and promote mucus demolition by mucin-degrading proteins and 
eliciting host inflammation (33, 182).  Genetic alterations leading to the lack of an intestinal 
mucus layer promote spontaneous colitis in mice (88), though this has yet to be studied in the 
germ-free animal.  In our studies, we noticed up to the time of weaning, neonates secrete mucus, 
but it fails to organize into structured layers, and was often seen detached from the intestinal 
epithelium.  For the neonates, this absence of a secured mucus layer led to direct bacterial-
epithelial cell interaction.  No neonates in our experiments developed colitis, or any other signs of 
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overt internal inflammation that might have been caused by this intimate interaction.  However, 
neonates not receiving passive SIgA almost always showed large amounts of O. anthropi in their 
MLNs, and it was never found in neonates gaining SIgA from their mothers.  Since no differences 
in O. anthropi fecal abundance were seen in neonate treatment groups, passive SIgA 
supplementation likely was working by some type of mechanism to impede translocation across 
the epithelium.  In humans, O. anthropi is considered an emerging opportunistic pathogen, and 
preterm infants have been found to be especially susceptible to infection of the peritoneal cavity 
(285).  It would be worthwhile to assay mouse and human milk to see if antibodies exist against 
this specific bacterium, as it is known maternally-supplemented SIgA has been found to have 
specificity against bacterial species and strains of viruses (324).   Our work should give even 
more credence to the idea of maternal milk as a prophylactic against bacterial invasion, especially 
in the immunocompromised infant. 
                 When adult mice were genetically altered to not produce intestinal mucus, we found 
that the entire arrangement of the intestine was altered.  Upon visual inspection, colonic crypts 
were greatly narrowed and elongated compared to the wild type mouse.  Without a mucus layer to 
provide structure, SIgA and SC were found to be in diffuse globular arrangements.  The most 
striking finding was the deep invasion of crypts by the intestinal microbiota, regardless of the 
presence of SIgA or pIgR/SC.  Goblet cell atrophy is a common finding during severe 
inflammation in humans (171).  Our findings would suggest that destruction of the intestinal 
mucus layer likely obliterates the assortments of molecules that home to this gel layer to provide 
immune functions.  Once the scaffolding is broken, all homeostatic proteins secreted by the 
epithelium likely lose much of their effectiveness, and the microbiota is allowed to be in close 
contact with the epithelial cell.  Furthermore, during goblet cell atrophy, the architecture of the 
crypt is also disrupted, which likely allows increased permeability of the epithelium.  The SCFA 
butyrate is known to increase MUC2 expression in CECs (85), and butyrate enemas have been 
used for over 20 years to ameliorate disease in ulcerative colitis patients (327).  Though butyrate 
is known to affect CECs in many ways, perhaps one mechanism to aid the colonic mucosa is to 
increase the amount of mucus filling goblet cells which would improve crypt integrity.               
 Assigning causality to bacterial-induced effects of epithelial gene expression which 
modulates intestinal bacterial communities which differentially stimulates epithelial cells.  
Within the organism, it is sometimes very difficult to assign succession to microbial-induced 
changes in gene expression.  For instance, a factor common to all human inflammatory bowel 
diseases is the tremendous increase in quantities of chemokines, pro-inflammatory cytokines, 
growth factors, and heat-shock proteins produced by the epithelial cell (171).  Another common 
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feature of IBDs is a dysbiosis of the intestinal microbiota, which is changed most severely during 
a flare of inflammation (9).  These dysbiotic events are typically defined by an increase in the 
relative percentages of Enterobacteriaceae and a decrease in the once dominant phyla Firmicutes 
and Bacteroidetes.  So, the immediate logical progression arises: 1) Enterobacteriaceae induce 
strong pro-inflammatory events in epithelial and professional immune cells that would be in the 
intestine; 2) IBD patients experience uncontrolled inflammation; 3) IBD patients see a dramatic 
increase in the relative percentage of Enterobacteriaceae; ergo 4) Enterobacteriaceae exacerbates 
inflammation in IBDs.  However, an extensive list of IBD covariates and comorbidities now exist 
(Figure 1.1j), and it would be short-sighted to purely label IBD-characteristic epithelial gene 
expression as being microbial.  Equally, we would be naïve in simply stating that the intestinal 
dysbiosis is simply a consequence of the disease.  We identified two unique populations of 
intestinal microbiota in adult mice which were directly associated with whether those mice did or 
did not receive SIgA in milk during nursing.  In parallel, these two cohorts of mice also displayed 
differing patterns of gene expression in the epithelial cells of their colon.  It is enticing to directly 
relate the two findings, with the change in passive SIgA-modulated intestinal microbiota at the 
causative factor for unique populations of CEC gene expression.  Likewise, we could connect the 
findings by stating that reception of SIgA during nursing directly influenced CEC gene 
expression which led to the unique microbiota.  No data in the field of immunology has been 
presented showing direct stimulation of epithelial cell signaling pathways by SIgA or IgA (in any 
multimeric form), whether maternally-provided or endogenously-produced.  However, a clear 
connection has been made between the intracellular neutralization of MAMPs and dimeric IgA, 
which works by inhibiting the induction of PRR signaling cascades (105, 328).  In addition, SIgA 
binding to bacterial motifs has been shown to also inhibit the extracellular capacity of bacteria to 
signal to epithelial cells (29).  To connect the microbiota to presence (absence) of passive SIgA, 
we propose that passive SIgA subdues the early bacterial colonizers’ ability to be recognized by 
intestinal epithelial cells, thereby inhibiting certain gene expression by never allowing it to 
happen.  In addition to the direct effect passive SIgA would have on the intestinal microbiota 
(biofilm formation, etc.) (77), this early SIgA induced ‘not-signaling’ by the CECs would have 
results on maturation of the intestinal innate and adaptive immune systems.  This gene expression 
from the reduced-signaling of epithelial cells, as well as dendritic cells and other immune cell 
types, would condition the intestinal environment, and further perpetuate the dialogue between 
the host and microbe.  Other groups have presented convincing evidence that SIgA-bound 
bacteria are more readily taken up in M cells and antigen presenting cells, such as intestinal DCs 
(29, 112).  This uptake will allow antigen presentation to mucosal T and B cells to aid in their 
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microbiota-specific maturation.  In essence, we propose the change in CEC gene expression and 
microbiotas between our mice receiving and not receiving passive SIgA is simply because a 
different algorithm of languages was established in these mice, and continued into adulthood by 
perpetual cycling.  In humans, the microbial consortium begins to be much more stable after the  
first year of life (1, 70), indicating that both the microbiota and immune system have become 
accustomed to each other.  Early immune system patterning by the intestinal microbiota has been 
seen for mice artificially inoculated with different microbes soon after birth (71).  The desire of 
the host intestinal mucosa to cultivate a beneficial microbiota is also supported by the evidence of 
factors secreted into the intestinal lumen to promote biofilm formation and other types of 
persistence mechanisms (147).  Extension of this work should longitudinally follow humans 
exclusively breastfed and exclusively formula fed for the first 6 months of life to see if 
separations arise in adulthood.  Additionally, other variables to be considered include the duration 
of breastfeeding, and if the children were ever supplemented with formula.  Figure 6.1 illustrates 
the perpetual microbe-intestinal cycle some of the languages used by each party. 
 Host and microbe both exist on the island that is the human body.  Eons of time have 
established a mutualism that humanity is only now beginning to understand, but also disturb in 
alarming ways.  As we continue to improve humanity’s quality of life, we cannot forget our 
friends.         
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Figure 6.1 Perpetual cycle of host-bacterial dialogue.  Intestinal recognition of bacteria through 
PRRs, dendritic cells, and other mechanisms leads to changes in gene expression and immune 
system maturation, which affects the microbiota……..ad mortem.    
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